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Abstract This manuscript describes the application of α,β-unsaturated acyl 
ammonium intermediates in a Michael-Michael-lactonisation cascade 
process to furnish δ-lactones. Generation of α,β-unsaturated acyl ammonium 
intermediates was achieved upon addition of isothiourea catalyst HyperBTM 
into α,β-unsaturated acid chlorides. Subsequent reaction with enone-
malonates gave access to δ-lactones in 20-64% yield, 72.5:27.5 to 95:5 er and 
81:19 to >95:5 dr. Additionally, application of a ring-opening protocol yielded 
1,2,3,4-substituted cyclopentanes in 28-77% yield, 76:24 to 98:2 er and 86:14 
to >95:5 dr. Interestingly, highest er was observed at high reaction 
temperatures, with 70˚C proving optimal. This effect was investigated by 
conducting an Eyring analysis, which indicated that differential activation 
entropy rather than differential activation enthalpy is responsible for 
enantiodiscrimination in this process. 
Key words Lewis base catalysis, α,β-unsaturated acyl ammonium 
intermediates, isothiourea catalysis, cascades, enantioselective catalysis 
 
The use of cascade sequences in enantioselective organic 
synthesis has long been considered a “gold standard” in the field, 
as complex product architectures can be elegantly and 
efficiently built up from simple, achiral starting materials.1,2 
Historically, the development of organocatalysis was driven by 
a desire to mimic the chemistry of enzyme catalysis using small 
molecules, and since many complex biosyntheses are facilitated 
by enzyme-catalysed cascade processes3 the development of 
organocatalyzed cascades is of great interest to the synthetic 
community.4 Lewis base catalysis is a versatile way of achieving 
cascade reactions, and many examples that exploit the 
interconnected nature of enamine and iminium intermediates 
are known.5  
Recent advances in this area have shown that α,β-
unsaturated acyl ammonium and azolium species can be used as 
intermediates in cascade reactions.6 An early example was 
reported by Studer et al. in 2011, who applied a Michael-
Michael-lactonisation approach to the NHC-catalysed synthesis 
of functionalised indanes. Enantioselective addition of 
dicarbonyl nucleophiles to an α,β-unsaturated acyl azolium 
species (generated in-situ under oxidative NHC catalysis) 
containing a tethered enone, followed by subsequent Michael 
addition and lactonisation allowed a cascade approach to these 
valuable products to be accessed (Approach A).7 An alternative 
approach to cascade cyclisation was adopted by Romo et al. who 
employed malonates with a tethered ketone functionality  
 
Figure 1 Proposed Michael-Michael lactonisation cascade reaction 
as a dual Michael donor-electrophile in the synthesis of β-
lactones via a Michael-aldol-lactonisation reaction (Approach 
B). This strategy relies on the in-situ catalytic generation of an 
α,β-unsaturated acyl ammonium intermediate (Figure 1(i)), 
with Michael addition, followed by an aldol-lactonisation 
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reaction of the resultant ammonium enolate generating the 
desired products.8 The same product architectures have also 
been accessed in analogous NHC-catalysed processes by the 
groups of Lupton9 and Studer,10 respectively. Building upon this 
work, and our own expertise in the utility of isothioureas11 in 
enantioselective catalysis,12 we looked to further the utility of 
α,β-unsaturated acyl ammonium intermediates13 by applying 
them in a Michael-Michael-lactonisation cascade. In this process, 
the use of Michael donor-acceptor substrates containing a 
malonate and a tethered enone and their reaction with a 
catalytically generated α,β-unsaturated acyl ammonium 
intermediate was envisaged (Figure 1(ii), Approach B). Since 
embarking on this work, three independent but related NHC-
catalysed processes that also target these substrates in an 
analogous strategy using an in-situ generated α,β-unsaturated 
acyl azolium species under oxidative catalysis have been 
published.14,15,16  Our approach differs in that oxidative catalysis 
is not employed, with the ,-unsaturated acyl ammonium 
species being generated directly at the carboxylic acid oxidation 
level from an acid chloride. 
Results and Discussion 
Optimisation 
Initial screening of the proposed Michael-Michael-Lactonisation 
(MML) reaction utilised enone-malonate 1a as the model 
nucleophile-electrophile component, and cinnamoyl chloride as 
the α,β-unsaturated acyl ammonium precursor (Table 1). 
LiHMDs was added to enone-malonate 1a at 0 °C in THF. After 
stirring for 10 minutes, iPr2NEt and isothiourea catalyst 
HyperBTM 4 were added, and the resultant mixture was 
allowed to stir at 0 °C for a further 10 minutes. Cinnamoyl 
chloride was then added as a solution in CH2Cl2, and the reaction 
was stirred and allowed to warm to rt overnight, giving a 76:24 
mixture of two products, 2a and 3a, which were isolated in 31% 
and 13% yield, respectively. The expected product of this 
cascade reaction 2a was formed in 69:31 er, with the 
observation of 3a postulated to be due to competitive 1,2-
addition of malonate 1a to cinnamoyl chloride. To probe the 
observed chemoselectivity of initial malonate addition and 
enantioselectivity of the process, further studies were 
performed at 0% and 100% catalyst loading (Table 1). With no 
catalyst present (0 mol%), an 87:13 ratio of 1,2-addition 
product 3a and 1,4-addition product 2a was generated. 
Alternatively, at 100 mol% catalyst loading the reaction 
proceeded to form only the cascade reaction product 2a, that is 
initiated by 1,4-addition, in 72.5:27.5 er. These observations 
suggest that (i) the undesired product 3a arises from direct 1,2-
addition to the acid chloride; (ii) the isothiourea-catalysed 
reaction results in excellent selectivity for the product arising 
from 1,4-addition; (iii) the poor enantioselectivity observed 
under these conditions is in part due to competitive generation 
of this product in racemic form from direct reaction with the 
acid chloride. Alternative isothiourea catalysts were also 
trialled. Reaction in the presence of 20 mol% of either BTM 5 or 
tetramisole (TM) 6 proceeded to 87 and 85% conversion 
respectively (with respect to 1a), with the 1,2-addition product 
3a predominating. For the BTM 5 catalysed reaction, a 33:67 
mixture of 1,4-addition product 2a (79:21 er) and 1,2-addition 
product 3a was isolated. Similarly, reaction with TM 6 gave an 
18:82 mixture of 2a (72.5:27.5 er) and 1,2-addition product 3a. 
All subsequent optimisation utilised HyperBTM 4, as this 
catalyst gave superior conversion to desired product 2a. 
 
Scheme 1 Reagents and conditions: (i) LiHMDS (1.1 equiv.), THF, 0 °C, 10 min; 
(ii) iPr2NEt (1.4 equiv.), catalyst (see Table XX), CH2Cl2, 0 °C, 10 min; (iii) 
cinnamoyl chloride (1.4 equiv.), CH2Cl2, 0 °C to rt, 18 h. 
Table 1 Initial reaction screen. 
Further reaction optimisation began with a solvent 
screen (Table 2). Mixtures of CH2Cl2 and THF have been 
reported to give high enantioselectivity in Romo’s related 
Michael-Aldol-Lactonisation protocol (Figure 1),8 thus an 
investigation into the relationship between solvent mixture 
composition and selectivity was analysed (Table 2). In general, 
the higher the proportion of CH2Cl2 in the reaction solvent, the 
lower the enantioselectivity, and the lower the proportion of 
1,4-addition product 2a (entries 1-5). In contrast, increased 
selectivity for the 1,4-addition product was generally observed 
at higher THF content. The best enantioselectivity was obtained 
at 90-100% THF content (entries 4 and 5), with a 84:16 ratio of 
2a (74.5:25.5 er):3a afforded in 100% THF. The effect of 
temperature upon the reaction manifold was explored next. 
Decreasing the reaction temperature to −78 °C gave 82% 
conversion to a 43:57 mixture of 2a and 3a. Interestingly, 2a 
was almost racemic, with an er of 51:49. Conversely, as the 
reaction temperature was increased, the enantioselectivity of 
the process also increased, with the highest selectivity observed 
at 70 °C. At this temperature, 85% conversion to a 54:46 mixture 
of 2a and 3a was observed, and desired 1,4-addition product 2a 
was formed in 87:13 er. Attempts to further improve the 
enantioselectivity by heating the solvent above its boiling point 
in a sealed tube, resulted in reduced material recovery, 
presumably due to degradation of the starting material under 
these conditions. Similarly, using dioxane as solvent/co-solvent 
resulted in lower conversion to the desired product 2a. 
catalyst catalyst loading 
(mol%) 
conv. 2a 3a er 
 
4 
20 100% 76 24 69:31 
0 75% 13 87 - 
100 100% 100 0 72.5:27.5 
5 20 87% 33 67 79:21 
6 20 85% 18 82 72.5:27.5 
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Scheme 2 Reagents and conditions: (i) LiHMDS (1 equiv.), solvent (see table), 0 °C, 10 min; (ii) base 2 (1.4 equiv., see table), HyperBTM 4 (20 mol%), 0 °C, 10 min; (iii) 
cinnamoyl chloride (1.4 equiv.), %), solvent (see table), temperature (see table).  
Table 2 Reaction optimisation 
Entry CH2Cl2 (%) THF (%) Temperature 
( °C) 
base 2 conv. 2a 3a er 
1 80 20 0 °C to rt iPr2NEt 100% 59 41 54:46 
2 40 60 0 °C to rt iPr2NEt 100% 63 37 62.5:37.5 
3 30 70 0 °C to rt iPr2NEt 100% 76 24 69:31 
4 10 90 0 °C to rt iPr2NEt 100% 58 42 74.5:25.5 
5 0 100 0 °C to rt iPr2NEt 88% 84 16 74.5:25.5 
6 0 100 -78 iPr2NEt 82% 43 57 51:49 
7 0 100 0 iPr2NEt 89% 63 37 75.5:24.5 
8 0 100 20 iPr2NEt 91% 70 30 80:20 
9 0 100 40 iPr2NEt 85% 67 33 85:15 
10 0 100 70 iPr2NEt 85% 54 46 87:13 
11 0 100 70 - 42% 57 43 91:9 
12 0 100 70 Cs2CO3 62% 67 33 88:12 
a Insert table footnotes here. 
 
 
Figure 2 Proposed influence of Lithium cation chelation on the ratio of 1,4- 
and 1,2-addition products. 
Further optimisation varied the base and probed its 
effect on product ratio and er. Carrying out the reaction without 
iPr2NEt gave low (42%) conversion of starting material, 
suggesting that this second base may be important for catalyst 
turnover. Cs2CO3 was also a suitable base for this function, giving 
a 67:33 ratio of 2a (88:12 er) and 3a, albeit with reduced 62% 
conversion. Earlier studies had indicated that LiHMDS was 
crucial to achieve a high ratio of 1,4-addition to 1,2-addition 
products.17 This observation is consistent with chelation by the 
lithium counter-ion being required to aid pre-organisation of 
the transition state of the intramolecular Michael addition, thus 
leading to preferential 1,4-addition over the 1,2-addition that is 
favoured in the absence of Li+(Figure 2).  
The unusual dependence of the enantioselectivity of 
this reaction with temperature prompted us to conduct a kinetic 
analysis using an Eyring plot. The rate of formation of 
(4S,7R,7aR)-2a, relative to its enantiomer (4R,7S,7aS)-2a, is 
related to the differential activation enthalpy (ΔΔH‡) and 
differential activation entropy (ΔΔS‡) according to equation 1.18 
ln (
𝐾(𝑆,𝑅,𝑅)
𝐾(𝑅,𝑆,𝑆)
) =
−∆∆𝐻‡
𝑅𝑇
+
∆∆𝑆‡
𝑅
 
Equation 1 Differential Eyring equation 
The natural logarithm of the enantiomeric ratio of (4S,7R,7aR)-
2a, measured from reactions conducted at a range of 
temperatures, was plotted as a function of reciprocal 
temperature,19 to give a straight line with a good correlation 
coefficient (0.984). This is consistent with a single mechanism 
operating over this temperature range, in which the same step 
is responsible for determining enantioselectivity.21,22,23 The 
activation parameters ΔΔH‡ and ΔΔS‡ are accessible from the 
Eyring plot, and determination of these values indicated that the 
ΔΔS‡ term (+4.42 Jmol−1K−1) is dominant over the ΔΔH‡ term 
(−0.865 kJmol−1) in the enantiodiscrimination of this reaction. 
Entropically controlled enantioselectivity may suggest that the 
origin of this temperature effect is conformational flexibility in 
the diastereomeric transition states. A similar effect has 
previously been observed in other systems where chelation is 
expected to play a key role in determining enantioselectivity, 
accounting for sensitivity to changes in temperature.23 
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Figure 3 Linear Eyring plot of the enantiomeric ratios obtained in the Michael-
Michael lactonisation cascade reaction. 
Under optimised conditions and upon scale-up of the reaction, a 
70:30 ratio of 2a to 3a was achieved, enabling isolation of 2a as 
a single diastereoisomer in 41% yield and 90.5:9.5 er (Scheme 
3). The relative configuration of the major diastereoisomer was 
determined via NOE analysis, and the absolute configuration 
was confirmed via comparison of its specific rotation value with 
that of a known compound {[α]D
20  (c1.0 in CHCl3), 82% ee; 
{lit.15 for enantiomer [α]D
20 −48.0 (c1.6 in CHCl3), 90% ee}.  
Scope and Limitations 
With this optimised condition set in hand, investigations into the 
scope of the developed reaction were undertaken. Initially the 
nucleophilic malonate component was varied (Scheme 3). Upon 
annulation with cinnamoyl chloride, the ratio of the 
constitutional isomer products B:C derived from 1,4- and 1,2-
addition varies between 61:39 to 77:23. Use of dimethyl 
malonate led to increased 1,4-:1,2-addition ratio (75:25 2b:3b) 
and gave an increased 63% yield of 1,4-addition product 2b in 
85.5:14.5 er. Benzyl substitution was also well tolerated, giving 
a 77:23 mixture of 2c and 3c, from which 2c was isolated in 54% 
yield and 86:14 er. In most cases the starting material was fully 
converted during the reaction time, however the use of bulky 
isopropyl substituted enone-malonate gave a slower reaction, 
which afforded 1,4-product 2d, 1,2-product 3d and starting  
material 1d in a 51:22:16 crude mixture. Upon purification, this 
afforded 2d in 44% yield and 82.5:17.5 er. Extending the 
reaction time increased degradation products and did not 
increase the yields of either 1,4- or 1,2-addition products.  
 
Scheme 4 Variation of acid chloride component: Reagents and conditions: (i) 
LiHMDS (1.1 equiv.), THF, 0 °C, 10 min; (ii) iPr2NEt (1.4 equiv.), HyperBTM 4 
(20 mol%), 0 °C, 10 min; (iii) acid chloride (1.4 equiv.), THF, 70 °C, 2 h. 
 
 
Scheme 3– Reaction scope: Variation of malonate component:  
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Reagents and Conditions: (i) LiHMDS (1 M in THF, 1.1 equiv), THF, 0 °C, 10 min; (ii) iPr2NEt (1.4 equiv, HyperBTM 2 (20 mol%),0 °C, 10 min; (iii) acid chloride (1.4 equiv), 
THF, 70 °C, 2 h. [a]Isolated as a mixture of 1,2 (3d)-addition product 3d and starting material 1d (7:3, inseparable by chromatography) 
 
The scope with respect to substitution on the acid chloride 
component was investigated next. Reaction between dibenzyl 
malonate 1c and commercially available crotonoyl chloride (R2 
= Me) gave a 77:23 mixture of 2e and 3e, from which 2e was 
isolated in 54% yield and 95.0:5.0 er. Reaction with dimethyl 
malonate 1b gave a 73:27 mixture of 1,4- and 1,2-addition 
products, enabling isolation of 2f in 56% yield and 93.5:6.5 er. 
Aromatic substitution of the acid chloride was also investigated, 
using a dimethyl malonate/phenyl enone coupling partner. 
Reaction with cinnamoyl chloride gave 2g in 64% yield, 
82.0:18.0 er and 88:12 dr.24 Electron rich aromatics showed a 
pronounced reduction in enantioselectivity, but increase in 
diastereoselectivity, giving p-OMe substituted 2h in 37% yield, 
72.0:28.0 er and 92:8 dr. 
For some of the acid chlorides trialled, the corresponding 
lactones were obtained in poor isolated yields. Upon reaction of 
1g with crotonyl chloride, lactone 2i was obtained in 32% yield, 
93.5:6.5 er and 85:15 dr (Scheme 4). Similarly, incorporation of 
an electron withdrawing p-CF3 substituent within the acid 
chloride component gave lactone 2j in just 20% yield, and 
82.5:17.5 er and 81:19 dr. Synthesis of heteroaromatic lactones 
was also attempted: thiophene substituted derivative 2k was 
obtained in high 85% NMR yield, but upon attempted 
chromatographic isolation ring opening of this lactone was 
observed, and cyclopentane 7k was instead isolated in 11% 
yield. To overcome these isolation issues, an alternative ring-
opening protocol was adopted (Scheme 4). The crude reaction 
mixture was treated with MeOH and DMAP to facilitate ring-
opening, resulting in products that it was hoped would be more 
stable to chromatographic purification. Following this 
approach, reaction of 1g with crotonoyl chloride, with 
subsequent ring-opening, gave 7i in an enhanced 77% yield, 
93.0:7.0 er and 93:7 dr. Similarly, p-CF3 substituted substrate 7j 
was obtained in 64% yield, 82.5:17.5 er and 84:16 dr, whilst 
thiophene derivative 7k was isolated in a much improved 63% 
yield, 98:2 er and 89:11 dr. 
The substituent at the electrophilic enone component was 
varied next (Scheme 5). Electron rich p-OMe aromatic enone 1l 
was reacted with both crotonoyl and cinnamoyl chloride. Upon 
reaction with crotonoyl chloride with subsequent ring-opening, 
7l was obtained in 37% yield and 96:4 er and as a single 
diastereoisomer. Isolation of the corresponding lactone was 
also attempted, but this did not improve the yield. Reaction with 
cinnamoyl chloride saw a reduction in stereoselectivity, giving 
7m in 40% yield, 81:19 er and 89:11 dr. Introducing a p-Me 
substituent into the aromatic enone gave 7n in 51% yield, 
84.5:15.5 er and 88:12 dr upon reaction with cinnamoyl 
chloride, whereas p-F substituted enone gave 7o in 30% yield, 
76:24 er and 93:7 dr. Incorporation of electron withdrawing 
aromatic substitutents on the enone portion gave a significant 
reduction in reactivity, and thus were not investigated further. 
 
Scheme 5 Variation of enone component: Reagents and Conditions: (i) 
LiHMDS (1 M in THF, 1.1 equiv), THF, 0 °C, 10 min; (ii) iPr2NEt (1.4 equiv, 
HyperBTM 4 (20 mol%),0 °C, 10 min; (iii) acid chloride (1.4 equiv), THF, 70 °C, 
2 h. 
It is postulated that the mechanism of this cascade reaction 
begins with acylation of the isothiourea catalyst 4 by the 
requisite acid chloride. Anion 9 could then add in either a 1,2- or 
a 1,4-fashion, yielding either 3a or 2a respectively. In the case of 
1,4-addition, turnover from intermediate 11 is achieved via 
lactonisation, giving rise to product 2a and regenerating catalyst 
4. Product of 1,2-addition 3a could also be formed via direct 
attack of anion 9 on the acid chloride, consistent with the high 
proportion of this product observed in the background reaction 
(Figure 4). The observed stereochemical outcome is proposed 
to arise from an initial Michael addition onto the Re-face of α,β-
unsaturated acyl ammonium 8, which is conformationally 
locked due to a stabilising non-bonding O–S interaction (nO to 
σ*C-S),25,26 with the Si-face effectively blocked by the 
stereodirecting groups on the isothiourea catalyst. 
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Figure 4 Proposed mechanism for the developed Michael-Michael Lactonisation cascade process. 
Conclusion 
In conclusion, as part of our efforts to explore the chemistry of 
α,β-unsaturated acyl ammonium intermediates we have 
demonstrated the first isothiourea-catalysed Michael-Michael-
lactonisation process, utilising enone-malonates as Michael 
donor-acceptor species alongside α,β-unsaturated acyl 
ammonium intermediates, generated in situ from addition of 
HyperBTM 4 into α,β-unsaturated acid chlorides. Under the 
optimised conditions stereodiscrimination is governed by 
differential reaction entropy rather than enthalpy, accounting for 
the enhanced enantioselectivity observed at elevated 
temperatures. This reaction has been applied to a range of enone-
malonates, affording 10 δ-lactones in 20-64% yield, 72.5:27.5 to 
95:5 er and 81:19 to >95:5 dr and 7 1,2,3,4-substituted 
cyclopentanes in 28-77% yield, 76:24 to 98:2 er and 86:14->95:5 
dr. Research into further applications of α,β-unsaturated acyl 
ammonium intermediates in enantioselective organocatalysis is 
ongoing within our laboratory. 
The experimental section has no title; please leave this line here. 
Reactions were performed in flame-dried glassware under an Ar or N2 
atmosphere unless otherwise stated. Anhydrous CH2Cl2, Et2O, THF and 
toluene were obtained from an MBraun SPS-800 system. Petrol is defined 
as petroleum ether 40‒60 °C. All other solvents and commercial reagents 
were used as received without further purification unless otherwise 
stated. Room temperature (rt) refers to 20‒25 °C. Temperatures of 0 °C 
and 78 °C were obtained using ice/water and CO2(s)/acetone baths 
respectively.  
  Analytical thin layer chromatography was performed on pre-coated 
aluminium plates (Kieselgel 60 F254 silica). Plates were visualised under 
UV light (254 nm) or by staining with either phosphomolybdic acid or 
KMnO4 followed by heating. Flash column chromatography was 
performed on Kieselgel 60 silica in the solvent system stated under a 
positive pressure of compressed air or on a Biotage® IsoleraTM 4, using 
Biotage® Snap Ultra or Biotage® KP Sil columns under the solvent system 
stated.  
  Melting points were recorded on an Electrothermal 9100 melting point 
apparatus. Optical rotations were measured on a Perkin Elmer 
Precisely/Model-341 polarimeter operating at the sodium D line with a 
100 mm path cell at 20 °C.  
  HPLC analyses were obtained on a Shimadzu HPLC consisting of a DGU-
20A5 degasser, LC-20AT liquid chromatography SIL-20AHT autosampler, 
CMB-20A communications bus module, SPDM20A diode array detector 
and a CTO-20A column oven that allows the temperature to be set from 
25‒40 °C. Separation was achieved using Chiralcel columns.  
  Infrared spectra (νmax) were recorded on a Shimadzu IRAffinity-1 Fourier 
transform IR spectrophotometer using either thin film or solid using Pike 
MIRacle ATR accessory. Analysis was carried out using Shimadzu 
IRsolution v1.50 and only characteristic peaks are reported.  
  1H, 13C{1H}, and 19F{1H} NMR spectra were recorded on Bruker Avance 
500 MHz, Bruker Avance 400 MHz and Bruker Avance 300 MHz NMR 
spectrometers. In CDCl3, 1H and 13C{1H} NMR chemical shifts are reported 
relative to CHCl3 at 7.27 ppm and 77.0 ppm, respectively. Coupling 
constants (J) are reported in Hertz (Hz). Multiplicities are indicated by: br 
s (broad singlet), s (singlet), d (doublet), t (triplet), q (quartet) and m 
(multiplet).  
  Mass spectrometry (m/z) data were acquired by electrospray ionisation 
(ES) or nanospray ionisation (NSI) either at the University of St Andrews 
or the EPSRC National Mass Spectrometry Service Centre, Swansea. At the 
University of St Andrews, low and high resolution ESI MS were carried out 
on a Micromass LCT spectrometer. At the EPSRC National Mass 
Spectrometry Service Centre, low resolution NSI MS was carried out on a 
Micromass Quattro II spectrometer and high resolution NSI MS on a 
Thermofisher LTQ Orbitrap XL spectrometer. 
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General Procedures 
General Procedure A: Enone-Malonate Synthesis via Cross Metathesis: 
Allylation procedure from Han and Widenhoefer.27 NaH (60% in mineral 
oil, 1 equiv) was suspended in DMF (0.35 M) at 0 ˚C. A solution of 
dicarbonyl (1 equiv) in DMF (1 M) was added and the flask stirred at 0 ˚C 
for 2 h. A solution of allylbromide (1 equiv) in DMF (1 M) was added 
dropwise and the flask stirred at 0 ˚C to rt for 16 h. Water (xx mL) was 
added and the mixture extracted with Et2O (xx mL × 2). The combined 
organic layers were washed with brine (xx mL × 3), dried over MgSO4, 
filtered and concentrated in vacuo to give the crude allyl ester (used 
without further purification). The allyl ester was dissolved in a solution of 
methyl vinyl ketone (3 equiv) in CH2Cl2 (0.5 M) in a sealable tube and the 
solution degassed by sparging with argon for 10 minutes. Metathesis 
catalyst M2 (2 mol%) was added, the tube sealed and heated at 50 ˚C for 
48 h. After cooling to rt the solution was concentrated in vacuo and 
purified by silica chromatography (passed through silica twice to remove 
Ru residues) to afford enone malonates. 
General procedure B: Synthesis of enone malonates via Wittig 
reaction: Dimethyl 2-(2-oxoethyl)malonate and the requisite ylid were 
stirred at rt in CHCl3 for 24 h, then concentrated in vacuo. The crude 
product was purified by column chromatography in the solvent system 
specified. 
General Procedure C: Acid Chloride Synthesis: Thionyl chloride (2 
equiv) was added dropwise to the requisite carboxylic acid (1 equiv) in 
dry CH2Cl2 (1.1 M) and DMF (few drops) at 0 °C, and the resultant mixture 
was stirred at reflux for 3 h. The solution was cooled to rt and the solvent 
was concentrated in vacuo to afford the product(s) which was used 
directly without further purification. 
General Produre D: Michael-Michael-Lactonisation: LiHMDS (1 M in 
THF, 1.1 equiv) was added to a solution of the requisite enone malonate 
(1 equiv) in dry THF (0.05 M) at 0 ˚C. After 5 minutes iPr2NEt (1.4 equiv) 
and HyperBTM 4 (20 mol%) were added then a reflux condenser added 
to the setup and the flask warmed to 70 ˚C. A solution of the requisite acid 
chloride (1.4 equiv) in THF (1 M) was added and the flask heated at 70 ˚C 
for 2 h. The solution was cooled to room temperature, diluted with EtOAc 
and washed sequentially with 0.1 M HCl and saturated aq NaHCO3 solution, 
dried over anhydrous MgSO4, filtered and concentrated in vacuo. The 
residue was purified by column chromatography on silica gel, in the 
solvent system specified, to afford the product(s). 
General Procedure E: Ring-opened products: LiHMDS (1 M in THF, 1.1 
equiv) was added to a solution of the requisite enone malonate (1 equiv) 
in dry THF (0.05 M) at 0 ˚C. After 5 minutes iPr2NEt (1.4 equiv) and 
HyperBTM 4 (20 mol%) were added and the flask warmed to 70 ˚C. A 
solution of acid chloride (1.4 equiv) in dry THF (1 M) was added and the 
flask heated at 70 ˚ C for 2 h. The solution was cooled to room temperature, 
diluted with EtOAc and washed sequentially with 1 M HCl, saturated aq 
NaHCO3 solution and brine, dried over anhydrous MgSO4, filtered and 
concentrated in vacuo. The obtained crude residue was dissolved in 
MeOH, and DMAP (20 mol%) was added. The reaction mixture was stirred 
at rt for 2 h. The solvent was removed in vacuo and the residue was 
purified by column chromatography on silica gel, in the solvent system 
specified, to afford the product. 
Experimental Procedures 
Diethyl (E)-2-(4-oxopent-2-en-1-yl)malonate 1a: Following General 
Procedure A, diethylmalonate (2.30 mL, 15.0 mmol in DMF, 15 mL), 
allylbromide (1.30 mL, 15.0 mmol in DMF, 15 mL) and NaH (60% in 
mineral oil, 0.60 g, 15.0 mmol) were reacted in DMF (40 mL). Aqueous 
work-up afforded crude allylmalonate which was dissolved in CH2Cl2 (40 
mL), and methyl vinyl ketone (3.65 mL, 45.0 mmol) and M2 (285 mg, 0.3 
mmol) were subsequently added. The residue was purified by silica 
chromatography (20% EtOAc/hexane) to afford 1a as a pale yellow oil 
(820 mg, 23%), with spectroscopic data in accordance with the 
literature.28 1H NMR (400 MHz, CDCl3) δH: 1.26 (6H, t, J 7.1, 2 × 
CO2CH2CH3), 2.22 (3H, s, COCH3), 2.79 (2H, td, J 7.2, 1.5, CH2CH=CH), 3.49 
(1H, t, J 7.3, CHCO2Et), 4.20 (4H, qd, J 7.1, 2.2, 2 × CO2CH2CH3), 6.11 (1H, 
dt, J 15.9, 1.5, CH2CH=CH), 6.73 (1H, dt, J 16.0, 7.0, CH2CH=CH).  
Dimethyl (E)-2-(4-oxopent-2-en-1-yl)malonate 1b: Following General 
Procedure A, dimethylmalonate (1.14 mL, 10.0 mmol in DMF, 10 mL), 
allylbromide (0.87 mL, 10.0 mmol in DMF, 10 mL) and NaH (60% in 
mineral oil, 0.40 g, 10.0 mmol) were reacted in DMF (40 mL). Aqueous 
work-up afforded crude allylmalonate which was dissolved in CH2Cl2 (20 
mL), and methyl vinyl ketone (2.43 mL, 30.0 mmol) and M2 (190 mg, 0.2 
mmol) were subsequently added. The residue was purified by silica 
chromatography (10-30% EtOAc/hexane) to afford 1b as an orange oil 
(522 mg, 23%), with spectroscopic data in accordance with the 
literature.14,16 1H NMR (300 MHz, CDCl3) δH: 2.20 (3H, s, COCH3), 2.78 (2H, 
td, J 7.1, 1.5, CH2), 3.52 (1H, t, J 7.3, CHCO2CH3), 3.72 (6H, s, 2 × OCH3), 6.09 
(1H, dt, J 16.0, 1.5, CH=CHCOCH3), 6.69 (1H, dt, J 16.0, 7.0, CH=CHCOCH3). 
Dibenzyl (E)-2-(4-oxopent-2-en-1-yl)malonate 1c: Following General 
Procedure A, dibenzylmalonate (2.50 mL, 10.0 mmol in DMF, 10 mL), 
allylbromide (0.87 mL, 10.0 mmol in DMF, 10 mL) and NaH (60% in 
mineral oil, 0.40 g, 10.0 mmol) were reacted in DMF (40 mL). Aqueous 
work-up afforded crude allylmalonate which was dissolved in CH2Cl2 (20 
mL), and methyl vinyl ketone (2.43 mL, 30.0 mmol) and M2 (190 mg, 0.2 
mmol) were subsequently added. The residue was purified by silica 
chromatography (10→20% EtOAc/hexane) to afford 1c as a pale orange 
oil (683 mg, 19%), with spectroscopic data in accordance with the 
literature.15 1H NMR (300 MHz, CDCl3) δH: 2.07 (3H, s, COCH3), 2.77 (2H, 
td, J 7.2, 1.5, CH2), 3.55 (1H, t, J 7.3, CHCO2Bn), 5.09 (4H, s, 2 × CO2CH2Ph), 
5.99 (1H, dt, J 16.0, 1.5, CH=CHCOCH3), 6.60 (1H, dt, J 16.0, 7.0, 
CH=CHCOCH3), 7.14 – 7.35 (10H, m, ArH). 
Diisopropyl (E)-2-(4-oxopent-2-en-1-yl)malonate 1d: Following 
General Procedure A, diisopropylmalonate (1.90 mL, 10.0 mmol in DMF, 
10 mL), allylbromide (0.87 mL, 10.0 mmol in DMF, 10 mL) and NaH (60% 
in mineral oil, 0.40 g, 10.0 mmol) were reacted in DMF (40 mL). Aqueous 
work-up afforded crude allylmalonate which was dissolved in CH2Cl2 (20 
mL), and methyl vinyl ketone (2.43 mL, 30.0 mmol) and M2 (190 mg, 0.2 
mmol) were subsequently added. The residue was purified by silica 
chromatography (10→20% EtOAc/hexane) to afford 1d as a pale yellow 
oil (526 mg, 19%); max (film)/cm-1 2982 (C-H), 2938 (C-H), 1724 (C=O), 
1676 (C=O), 1632 (C=C); 1H NMR (300 MHz, CDCl3) δH: 1.24 (12H, dd, J 6.2, 
1.5, 2 × CH(CH3)2), 2.23 (3H, s, COCH3), 2.78 (2H, td, J 7.2, 1.6, CH2), 3.43 
(1H, t, J 7.3, CHCO2iPr), 5.06 (2H, hept, J 6.3, CH(CH3)2), 6.12 (1H, dt, J 16.0, 
1.5, CH=CHCOCH3), 6.75 (1H, dt, J 16.0, 7.0 CH=CHCOCH3); 13C{1H} NMR 
(75 MHz, CDCl3) δC: 21.7 (2 × CH(CH3)2), 27.1 (COCH3), 31.3 (CH2), 51.1 
(CHCO2iPr), 69.5 (2 × CH(CH3)2), 133.2 (CH=CHCOCH3), 143.2 
(CH=CHCOCH3), 168.0 (2 × CO2iPr), 198.2 (COCH3); m/z (NSI+)288 
([M+NH4]+, 100%), 271 ([M+H]+, 55%); HRMS (NSI+)C14H23O5 ([M+H]+) 
requires 271.1540, found 271.1543. 
Dimethyl (E)-2-(4-oxo-4-phenylbut-2-en-1-yl)malonate 1g: Dimethyl 
(E)-2-(4-hydroxy-4-phenylbut-2-en-1-yl)malonate (1 equiv, 3.68 mmol, 
1.02 g) was dissolved in CH2Cl2 (27 mL) and activated MnO2 (20 equiv, 
73.58 mmol, 6.4 g) added. The flask was stirred at rt for 16 h then filtered 
through celite and concentrated in vacuo. Purification via column 
chromatography (CH2Cl2→ EtOAc/CH2Cl2 1:50) gave 1g as a pale yellow 
oil (686 mg, 2.48 mmol, 67%), with spectroscopic data in accordance with 
the literature.14,16 1H NMR (400 MHz, CDCl3) δH: 2.97-2.92 (2H, m, C(2)H2), 
3.63 (1H, t, J 7.4, C(1)H), 3.78 (6H, s, 2 × CO2CH3), 7.03 – 6.90 (2H, m, 2 × 
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CH=CH), 7.53-7.45 (2H, m, 2 × Ph), 7.63-7.55 (1H, m, Ph), 7.98-7.89 (2H, 
m, 2 × Ph). 
Dimethyl (E)-2-(4-(4-methoxyphenyl)-4-oxobut-2-en-1-yl)malonate 
1l: Following General Procedure B, dimethyl 2-(2-oxoethyl)malonate (977 
mg, 5.61 mmol) and 1-(4-methoxyphenyl)-2-(triphenyl-λ5-
phosphanylidene)ethan-1-one29 (2.53 g, 6.17 mmol) were reacted in 
CHCl3 (16 mL). Purification via column chromatography on silica gel 
(petrol/EtOAc, 3:1) gave 1l as a pale yellow sold (615 mg, 36%, >95:5 dr), 
with spectroscopic data in accordance with the literature.14,16 mp 55-58 
°C; 1H NMR (400 MHz, CDCl3) δH: 2.91 (2H, t, J 7.5, C(1)H2), 3.60 (1H, t, J 
7.5, CH(CO2Me)2), 3.76 (6H, s, CO2Me), 3.88 (3H, s, OMe), 6.83-7.06 (4H, m, 
C(2)H, C(3)H, Ar), 7.93 (2H, d, J 8.9, Ar). 
Dimethyl (E)-2-(4-oxo-4-(p-tolyl)but-2-en-1-yl)malonate 1n: 
Following General Procedure B, dimethyl 2-(2-oxoethyl)malonate (1.48 g, 
8.49 mmol) and 1-(p-tolyl)-2-(triphenyl-λ5-phosphanylidene)ethan-1-
one29 (3.68 g, 9.34 mmol) were reacted in CHCl3 (24 mL). Purification via 
column chromatography on silica gel (petrol/EtOAc, 4:1) gave 1n as an 
orange oil (806 mg, 33%, >95:5 dr), with spectroscopic data in accordance 
with the literature.16 1H NMR (400 MHz, CDCl3) δH: 2.41 (3H, s, Me), 2.90 
(2H, t, J 7.5, C(1)H2), 3.60 (1H, t, J 7.5, CH(CO2Me)2), 3.75 (6H, s, CO2Me), 
6.85-7.04 (2H, m, C(2)H, C(3)H), 7.26 (2H, d, J 8.2, Ar), 7.82 (2H, d, J 8.2, 
Ar). 
Dimethyl (E)-2-(4-(4-fluorophenyl)-4-oxobut-2-en-1-yl)malonate 
1o: Following General Procedure B, dimethyl 2-(2-oxoethyl)malonate 
(1.30 g, 7.76 mmol) and 1-(4-fluorophenyl)-2-(triphenyl-λ5-
phosphanylidene)ethan-1-one29 (3.27 g, 8.21 mmol) were reacted in 
CHCl3 (21 mL). Purification via column chromatography on silica gel 
(petrol/EtOAc, 4:1) gave 1o as a pale yellow oil (706 mg, 32%, >95:5 dr), 
with spectroscopic data in accordance with the literature.14,16 1H NMR 
(300 MHz, CDCl3) δH: 2.88-2.95 (2H, m, C(1)H2), 3.61 (1H, t, J 7.4, 
CH(CO2Me)2), 3.76 (6H, s, CO2Me), 6.90-6.97 (2H, m, C(2)H, C(3)H), 7.08-
7.20 (2H, m, Ar), 7.88-8.01 (2H, m, Ar); 19F{1H} NMR (376 MHz, CDCl3) δF: 
−105.3 (C(4ˈ)F). 
Diethyl (4aS,7R,7aR)-3-methyl-1-oxo-7-phenyl-4a,5,7,7a-
tetrahydrocyclopenta[c]pyran-6,6(1H)-dicarboxylate 2a and diethyl 
2-cinnamoyl-2-((E)-4-oxopent-2-en-1-yl)malonate 3a: Following 
General Procedure D, diethyl (E)-2-(4-oxopent-2-en-1-yl)malonate (121 
mg, 0.5 mmol), LiHMDS (1 M in THF, 0.55 mL, 0.55 mmol), HyperBTM 4 
(30.8 mg, 0.10 mmol), iPr2NEt (0.12 mL, 0.7 mmol) and cinnamoyl 
chloride (117 mg, 0.7 mmol) were reacted in THF (10 mL) to give a 68:32 
mixture of 2a and 3a in 68:32. The mixture was purified by 
chromatography on silica gel (20% EtOAc/hexane) to afford 2a as a pale 
yellow oil (76 mg, 41%) and 3a as a pale yellow oil (40 mg, 22%). 2a: 
[𝛼]𝐷
20 (c 1.07 in CH2Cl2); [𝛼]𝐷
20 (c 1.0 in CHCl3); {lit.15 for 
enantiomer [𝛼]𝐷
20 −48.0 (c 1.6 in CHCl3), 90% ee}; chiral HPLC analysis, 
ChiralPak AD-H (5% i-PrOH:hexane, flow rate 1 mL min-1, 211 nm, 30 °C), 
tR (4aS,7R,7aR): 14.8 min, tR (4aR,7S,7aS): 16.5 min, 90.5:9.5 er; max 
(film)/cm-1 3032 (C-H), 2982 (C-H), 1717 (C=O); 1H NMR (500 MHz, 
CDCl3) δH: 0.75 (3H, t, J 7.1, CO2CH2CH3), 1.25 (3H, t, J 7.0, CO2CH2CH3), 1.88 
(3H, dd, J 2.2, 1.1, C(3)CH3), 2.16 (1H, dd, J 13.9, 4.0, C(5)HA), 3.03 (1H, dd, 
J 13.9, 7.3, C(5)HB), 3.29 – 3.46 (3H, m, CO2CHAHBCH3, C(4a)H, C(7a)H), 
3.73 (1H, dq, J 10.7, 7.1, CO2CHAHBCH3), 4.15 – 4.29 (2H, m, CO2CH2CH3), 
4.63 (1H, d, J 9.4, C(7)H), 4.77 (1H, dt, J 3.1, 1.2, C(4)H), 7.20 – 7.25 (1H, m, 
p-Ph), 7.25 – 7.30 (2H, m, 2 × m-Ph), 7.31 – 7.36 (2H, m, 2 × o-Ph); 13C{1H} 
NMR (125 MHz, CDCl3) δC: 13.4 (CO2CH2CH3), 14.1 (CO2CH2CH3), 18.9 
(C(3)CH3), 36.3 (C(4a)H), 41.3 (C(5)H2), 47.7 (C(7a)H), 53.4 (C(7)H), 61.6 
(CO2CH2CH3), 61.9 (CO2CH2CH3), 65.0 (C(6)), 102.4 (C(4)H), 127.7 (p-Ph), 
128.2 (2 × Ph), 129.0 (2 × Ph), 137.6 (i-Ph), 148.5 (C(3)CH3), 169.1 (C(1)), 
170.0 (CO2Et), 171.4 (CO2Et); m/z (NSI+) 390 ([M+NH4]+, 100%), 373 
([M+H]+, 50%); HRMS (NSI+)C21H24O6 ([M+H]+) requires 373.1646, found 
373.1650. 3a: max (film)/cm-1 2982 (C-H), 2934 (C-H), 1728 (C=O), 1676 
(C=O), 1609 (C=C); 1H NMR (400 MHz, CDCl3) δH: 1.27 (6H, t, J 7.1, 2 × 
CO2CH2CH3), 2.22 (3H, s, COCH3), 3.08 (2H, dd, J 7.3, 1.4, CH2CH=CH), 4.27 
(4H, q, J 7.1, 2 × CO2CH2CH3), 6.09 (1H, dt, J 15.9, 1.4, CH2CH=CH), 6.83 (1H, 
dt, J 16.0, 7.3, CH2CH=CH), 7.05 (1H, d, J 15.6, CH=CHPh), 7.33 – 7.45 (3H, 
m, Ph), 7.51 – 7.59 (2H, m, Ph), 7.72 (1H, d, J 15.6, CH=CHPh); 13C{1H} NMR 
(100 MHz, CDCl3) δC: 14.2 (2 × CO2CH2CH3), 26.7 (COCH3), 35.2 
(CH2CH=CH), 62.7 (2 × CO2CH2CH3), 70.0 (C(CO2Et)2), 122.5 (CH=CHPh), 
128.8 (2 × Ph), 129.1 (2 × Ph), 131.1 (p-Ph), 134.3 (i-Ph), 134.7 
(CH2CH=CH), 142.5 (CH2CH=CH), 144.5 (CH=CHPh), 167.1 (2 × CO2Et), 
189.3 (COCH=CHPh), 198.5 (COMe); m/z (NSI+) 390 ([M+NH4]+, 40%), 
373 ([M+H]+, 100%); HRMS (NSI+)C21H24O6 ([M+H]+) requires 373.1646, 
found 373.1652. 
Dimethyl (4aS,7R,7aR)-3-methyl-1-oxo-7-phenyl-4a,5,7,7a-
tetrahydrocyclopenta[c]pyran-6,6(1H)-dicarboxylate 2b and 
dimethyl 2-cinnamoyl-2-((E)-4-oxopent-2-en-1-yl)malonate 3b: 
Following General Procedure D, dimethyl (E)-2-(4-oxopent-2-en-1-
yl)malonate (107 mg, 0.5 mmol), LiHMDS (1 M in THF, 0.55 mL, 0.55 
mmol), HyperBTM 4 (30.8 mg, 0.10 mmol), iPr2NEt (0.12 mL, 0.7 mmol) 
and cinnamoyl chloride (117 mg, 0.7 mmol) were reacted in THF (10 mL) 
to give a 75:25 mixture of 2b and 3b. The mixture was purified by 
chromatography on silica gel (20%→30% EtOAc/hexane) to afford 2b as 
a pale yellow oil (108 mg, 63%) and 3b as a pale yellow oil (40 mg, 23%). 
2b: [𝛼]𝐷
20 (c 1.50 in CH2Cl2); chiral HPLC analysis, ChiralPak AS-H 
(5% i-PrOH:hexane, flow rate 1 mL min-1, 211 nm, 30 °C), tR (4aS,7R,7aR): 
13.2 min, tR (4aR,7S,7aS): 23.6 min, 85.5:14.5 er; max (film)/cm-1 2953 (C-
H), 1749 (C=O), 1727 (C=O), 1699 (C=O); 1H NMR (300 MHz, CDCl3) δH: 
1.89 (3H, dd, J 2.0, 1.1, C(3)CH3), 2.14 (1H, dd, J 13.9, 4.0 C(5)HA), 3.02 (1H, 
dd, J 14.1, 7.0, C(5)HB), 3.12 (3H, s, CO2CH3), 3.29 – 3.50 (2H, m, C(4a)H, 
C(7a)H), 3.75 (3H, s, CO2CH3), 4.63 (1H, d, J 9.0, C(7)H), 4.75 – 4.80 (1H, m, 
C(4)H), 7.00 – 7.48 (5H, m, ArH); 13C{1H} NMR (75 MHz, CDCl3) δC: 18.8 
(C(3)CH3), 36.2 (C(4a)H), 41.2 (C(5)H2), 47.4(C(7a)H), 52.3 (CO2CH3), 53.0 
(CO2CH3), 53.6 (C(7)H), 65.1 (C(6)), 102.3 (C(4)H), 127.7 (p-Ph), 128.2 
(Ph), 128.8 (Ph), 137.4 (i-Ph), 148.5 (C(3)), 168.9 (C(1)), 170.3 (CO2CH3), 
171.8 (CO2CH3); m/z (NSI+) 367 ([M+Na]+, 100%), 345 ([M+H]+, 65%); 
HRMS (NSI+) C19H21O6 ([M+H]+) requires 345.1333, found 345.1329. 3b: 
max (film)/cm-1 2955 (C-H), 1732 (C=O), 1674 (C=O), 1607 (C=C); 1H NMR 
(300 MHz, CDCl3) δH: 2.22 (3H, s, COCH3), 3.08 (2H, dd, J 7.3, 1.4, CH2), 3.80 
(6H, s, 2 × CO2CH3), 6.09 (1H, dt, J 16.0, 1.4, CH=CHCOCH3), 6.81 (1H, dt, J 
16.0, 7.3, CH=CHCOCH3), 7.00 (1H, d, J 15.6, CH=CHPh), 7.41 (3H, qd, J 2.9, 
1.1, Ph), 7.50 – 7.61 (2H, m, Ph), 7.73 (1H, d, J 15.6, CH=CHPh); 13C{1H} 
NMR (75 MHz, CDCl3) δC: 26.8 (COCH3), 35.3 (CH2), 53.5 (2 × CO2CH3), 70.1 
(C(CO2CH3), 122.1 (CH=CHPh), 128.9 (2 × Ph), 129.1 (2 × Ph), 131.2 (p-
Ph), 134.2 (i-Ph), 134.7 (CH=CHCOCH3), 142.1 (CH=CHCOCH3), 145.0 
(CH=CHPh), 167.5 (2 × CO2CH3), 189.0 (COCH=CHPh), 198.4 (COCH3); m/z 
(NSI+) 367 ([M+Na]+, 100%), 345 ([M+H]+, 20%); HRMS (NSI+) C19H21O6 
([M+H]+) requires 345.1333, found 345.1330. 
Dibenzyl (4aS,7R,7aR)-3-methyl-1-oxo-7-phenyl-4a,5,7,7a-
tetrahydrocyclopenta[c]pyran-6,6(1H)-dicarboxylate 2c and 
dibenzyl 2-cinnamoyl-2-((E)-4-oxopent-2-en-1-yl)malonate 3c: 
Following General Procedure D, dibenzyl (E)-2-(4-oxopent-2-en-1-
yl)malonate (183 mg, 0.5 mmol), LiHMDS (1 M in THF, 0.55 mL, 0.55 
mmol), HyperBTM 4 (30.8 mg, 0.10 mmol), iPr2NEt (0.12 mL, 0.7 mmol) 
and cinnamoyl chloride (117 mg, 0.7 mmol) were reacted in THF (10 mL) 
to give a 77:23 mixture of 2c and 3c. The mixture was purified by 
chromatography on silica gel (20% EtOAc/hexane) to afford 2c as a pale 
yellow oil (135 mg, 54%) and 3c as a pale yellow oil (41 mg, 16%). 2c: 
[𝛼]𝐷
20c 3.42 in CH2Cl2); chiral HPLC analysis, ChiralPak AD-H (5% i-
PrOH:hexane, flow rate 1 mL min-1, 211 nm, 30 °C), tR (4aS,7R,7aR): 35.6 
min, tR (4aR,7S,7aS): 38.4 min, 86.0:14.0 er; max (film)/cm-1 3034 (C-H), 
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1749 (C=O), 1724 (C=O); 1H NMR (300 MHz, CDCl3) δH: 1.84 (3H, dd, J 2.1, 
1.1, CH3), 2.21 (1H, dd, J 13.9, 3.9, C(5)HA), 3.07 (1H, dd, J 13.9, 7.2, C(5)HB), 
3.29 – 3.42 (1H, m, C(4a)H), 3.43 – 3.48 (1H, m, C(7a)H), 4.20 (1H, d, J 12.3, 
CO2CHAHBPh), 4.64 – 4.71 (2H, m, C(4)H, C(7)H), 4.75 (1H, d, J 12.3, 
CO2CHAHBPh), 5.06 (1H, d, J 12.1, CO2CHAHBPh), 5.17 (1H, d, J 12.1, 
CO2CHAHBPh), 6.85 – 6.91 (2H, m, Ph), 7.16 – 7.39 (13H, m, Ph); 13C{1H} 
NMR (75 MHz, CDCl3) δC: 18.8 (C(3)CH3), 36.3 (C(4a)H), 41.3 (C(5)H2), 
47.7 (C(7a)H), 53.7 (C(7)H), 65.2 (C(6)), 67.4 (CO2CH2Ph), 67.8 
(CO2CH2Ph), 102.3 (C(4)H), 127.8 (p-Ph), 128.0 (2 × Ph), 128.2 (p-Ph), 
128.4 (2 × Ph), 128.4 (2 × Ph), 128.4 (2 × Ph), 128.5 (p-Ph), 128.6 (2 × Ph), 
129.0 (2 × Ph), 134.7 (i-Ph), 135.2 (i-Ph), 137.3 (i-Ph), 148.6 (C(3)), 168.9 
(C(1)), 169.7 (CO2Bn), 171.0 (CO2Bn); m/z (NSI+) 497 ([M+H]+, 100%); 
HRMS (NSI+) C31H29O6 ([M+H]+) requires 497.1959, found 497.1944. 3c: 
max (film)/cm-1 3032 (C-H), 1730 (C=O), 1676 (C=O), 1608 (C=O); 1H 
NMR (300 MHz, CDCl3) δH: 2.11 (3H, s, CH3), 3.12 (2H, dd, J 7.4, 1.3, CH2), 
5.23 (4H, d, J 2.0, 2 × CO2CH2Ph), 6.02 (1H, dt, J 16.0, 1.3, CH=CHCOCH3), 
6.76 (1H, dt, J 15.9, 7.3 CH=CHCOCH3), 6.90 (1H, d, J 15.6, CH=CHPh), 7.23 
– 7.33 (10H, m, Ph), 7.33 – 7.40 (5H, m, Ph), 7.69 (1H, d, J 15.6, CH=CHPh); 
13C{1H} NMR (75 MHz, CDCl3) δC: 26.6 (CH3), 35.2 (CH2), 68.3 (4 × 
CO2CH2Ph), 122.6 (CH=CHPh), 128.5 (Ph), 128.7 (Ph), 128.7 (Ph), 128.8 
(Ph), 128.9 (Ph), 129.0 (Ph), 131.1 (Ph), 134.1 (i-Ph), 134.6 (2 × i-Ph), 
134.8 (CH=CHCOCH3), 142.1 (CH=CHCOCH3), 144.8 (CH=CHPh), 166.8 (2 
× CO2Bn), 188.7 (COCH=CHPh), 198.4 (COCH3); m/z (NSI+) 497 ([M+H]+, 
100%); HRMS (NSI+) C31H29O6 ([M+H]+) requires 497.1959, found 
497.1946. 
Diisopropyl (4aS,7R,7aR)-3-methyl-1-oxo-7-phenyl-4a,5,7,7a-
tetrahydrocyclopenta[c]pyran-6,6(1H)-dicarboxylate 2d and 
diisopropyl 2-cinnamoyl-2-((E)-4-oxopent-2-en-1-yl)malonate 3d: 
Following General Procedure D, diisopropyl (E)-2-(4-oxopent-2-en-1-
yl)malonate (135 mg, 0.5 mmol), LiHMDS (1 M in THF, 0.55 mL, 0.55 
mmol), HyperBTM 4 (30.8 mg, 0.10 mmol), iPr2NEt (0.12 mL, 0.7 mmol) 
in THF and cinnamoyl chloride (117 mg, 0.7 mmol) were reacted in THF 
(10 mL) to give a 61:39 mixture of 2d and 3d.The mixture was purified by 
chromatography on silica gel (10%→20% EtOAc/hexane) to afford 2d as 
a pale yellow oil (87 mg, 44%) and 3d as a pale yellow oil (isolated as a 
7:3 mixture of 3d to enone-malonate 1d, 71 mg, 36%). 2d: [𝛼]𝐷
20 (c 
0.58 in CH2Cl2); chiral HPLC analysis, ChiralPak AD-H (5% i-PrOH:hexane, 
flow rate 1 mL min-1, 211 nm, 30 °C), tR (4aS,7R,7aR): 10.2 min, tR 
(4aR,7S,7aS): 12.0 min, 82.5:17.5 er; max (film)/cm-1 2980 (C-H), 2924 (C-
H), 1763 (C=O), 1719 (C=O); 1H NMR (300 MHz, CDCl3) δH: 0.48 (3H, d, J 
6.3, CH(CH3)(CH)3), 1.01 (3H, d, J 6.2, CH(CH3)(CH)3), 1.24 (3H, d, J 6.3, 
CH(CH3)(CH)3), 1.28 (3H, d, J 6.2, CH(CH3)(CH)3), 1.89 (3H, dd, J 2.1, 1.1 
C(3)CH3), 2.19 (1H, dd, J 13.9, 3.5, C(5)HA), 3.03 (1H, dd, J 13.9, 7.1, 
C(5)HB), 3.26 – 3.48 (2H, m, C(4a)H, C(7a)H), 4.46 (1H, p, J 6.3, CH(CH3)2), 
4.62 (1H, d, J 9.0, C(4)H), 4.75 (1H, dq, J 2.9, 1.1, C(7)H), 5.09 (1H, p, J 6.2, 
CH(CH3)2), 7.19 – 7.38 (5H, m, Ph); 13C{1H} NMR (75 MHz, CDCl3) δC: 18.9 
(C(3)CH3), 20.7 (CH(CH3)(CH3)), 21.4, (CH(CH3)(CH3)) 21.6 
(CH(CH3)(CH3)), 21.8 (CH(CH3)(CH3)), 36.3 (C(4a)H), 41.6 (C(5)H2), 48.4 
(C(7a)H), 53.4 (C(7)H), 65.0 (C(6)), 69.4 (CH(CH3)2), 69.5 (CH(CH3)2), 
102.4 (C(4)H), 127.7 (p-Ph), 128.3 (2 × Ph), 129.2 (2 × Ph), 137.9 (i-Ph), 
148.6 (C(3)), 169.1 (C(1)), 169.5 (CO2iPr), 171.0 (CO2iPr); m/z (NSI+) 401 
([M+H]+, 100%), 423 ([M+Na]+, 65%); HRMS (NSI+) C23H29O6 ([M+H]+) 
requires 401.1959, found 401.1949. 3d: max (film)/cm-1 2982 (C-H), 1724 
(C=O), 1676 (C=O), 1609 (C=O); 1H NMR (300 MHz, CDCl3) δH: 1.25 (12H, 
d, J 6.3, 2 × CH(CH3)2), 2.21 (3H, s, COCH3), 3.05 (2H, dd, J 7.3, 1.4, CH2), 
5.12 (2H, p, J 6.3, 2 × CHCH3)2), 6.09 (1H, dt, J 16.1, 1.4, CH=CHCOCH3), 6.83 
(1H, dt, J 16.0, 7.3, CH=CHCOCH3), 7.06 (1H, d, J 15.7, CH=CHPh), 7.39 (3H, 
dd, J 5.1, 1.9, Ph), 7.48 – 7.59 (2H, m, Ph), 7.70 (1H, d, J 15.7, CH=CHPh); 
13C{1H} NMR (75 MHz, CDCl3) δC: 21.7 (CH(CH3)2), 21.7 (CH(CH3)2), 26.6 
(COCH3), 35.1 (CH2), 70.6 (2 × CH(CH3)2), 122.8 (CH=CHPh), 128.7 (2 × 
Ph), 129.1 (2 × Ph), 131.0 (p-Ph), 134.4 (i-Ph), 134.7 (CH=CHCOCH3), 142.7 
(CH=CHCOCH3), 144.0 (CH=CHPh), 166.6 (2 × CO2iPr), 189.6 
(COCH=CHPh), 198.5 (COCH3); m/z (NSI+) 401 ([M+H]+, 30%), 423 
([M+Na]+, 100%); HRMS (NSI+) C23H29O6 ([M+H]+) requires 401.1959, 
found 401.1949. 
Dibenzyl (4aS,7S,7aR)-3,7-dimethyl-1-oxo-4a,5,7,7a-
tetrahydrocyclopenta[c]pyran-6,6(1H)-dicarboxylate 2e and 
dibenzyl 2-((E)-but-2-enoyl)-2-((E)-4-oxopent-2-en-1-yl)malonate 
3e: Following General Procedure D, dibenzyl (E)-2-(4-oxopent-2-en-1-
yl)malonate (183 mg, 0.5 mmol), LiHMDS (1 M in THF, 0.55 mL, 0.55 
mmol), HyperBTM 4 (30.8 mg, 0.10 mmol), iPr2NEt (0.12 mL, 0.7 mmol) 
and crotonoyl chloride (67 μL, 0.7 mmol) were reacted in THF (10 mL) to 
give a 77:23 mixture of 2e and 3e. The mixture was purified by 
chromatography on silica gel (20% EtOAc/hexane) to afford 2e as a pale 
yellow oil (118 mg, 54%) and 3e as a pale yellow oil (30 mg, 14%). 2e: 
[𝛼]𝐷
20 (c 1.55 in CH2Cl2); chiral HPLC analysis, ChiralPak AD-H (5% 
i-PrOH:hexane, flow rate 1 mL min-1, 211 nm, 30 °C), tR (4aS,7S,7aR): 21.4 
min, tR (4aR,7R,7aS): 23.2 min, 95.0:5.0 er; max (film)/cm-1 2955 (C-H), 
1748 (C=O), 1722 (C=O);  1H NMR (400 MHz, CDCl3) δH: 1.15 (3H, d, J 6.9, 
C(7)CH3), 1.79 (3H, dd, J 2.3, 1.1, C(3)CH3), 2.06 (1H, dd, J 14.0, 4.3, 
C(5)HA), 2.73 (1H, ddd, J 11.1, 8.8, 0.9, C(7)H), 2.81 (1H, dd, J 13.9, 8.2, 
C(5)HB), 2.99 – 3.08 (1H, m, C(7a)H), 3.08 – 3.16 (1H, m, C(4a)H), 4.59 (1H, 
dp, J 2.1, 1.1, C(4)H), 4.98 – 5.19 (4H, m, 2 × CO2CH2Ph), 7.19 – 7.27 (4H, 
m, Ph), 7.29 – 7.37 (6H, m, Ph); 13C{1H} NMR (100 MHz, CDCl3) δC: 15.3 
(C(7)CH3), 18.8 (C(3)CH3), 34.9 (C(4a)H), 41.2 (C(5)H2), 44.2 (C(7)H), 48.4 
(C(7a)H), 62.4 (C(6)), 67.5 (CO2CH2Ph), 67.5 (CO2CH2Ph), 103.1 (C(4)H), 
128.3 (2 × Ph), 128.4 (2 × Ph), 128.5 (p-Ph), 128.6 (p-Ph), 128.6 (2 × Ph), 
128.7 (2 × Ph), 135.0 (i-Ph), 135.4 (i-Ph), 147.1 (C(3)), 169.6 (C(1)), 170.5 
(CO2Bn), 170.9 (CO2Bn); m/z (NSI+) 436 ([M+Na]+, 30%), 435 ([M+H]+, 
100%); HRMS (NSI+) C26H27O6+ ([M+H]+) requires 435.1802, found 
435.1798. 3e: max (film)/cm-1 2967 (C-H), 1728 (C=O), 1694 (C=O), 1676 
(C=O); 1H NMR (400 MHz, CDCl3) δH: 1.79 (3H, dd, J 7.0, 1.7, CH=CHCH3), 
2.06 (3H, s, COCH3), 3.01 (2H, dd, J 7.3, 1.4, CH2), 5.18 (4 H, d, J 1.4, 2 × 
CO2CH2Ph), 5.95 (1H, dt, J 16.0, 1.4, CH=CHCOCH3), 6.29 (1H, dq, J 15.2, 1.7, 
CH=CHCH3), 6.67 (1H, dt, J 16.0, 7.3, CH=CHCOCH3), 6.98 (1H, dq, J 15.2, 
7.0, CH=CHCH3), 7.19 – 7.30 (4H, m, Ph), 7.30 – 7.35 (6H, m, Ph); 13C{1H} 
NMR (100 MHz, CDCl3) δC: 18.4 (CH=CHCH3), 26.5 (COCH3), 35.1 (CH2), 
68.2 (2 × CO2CH2Ph), 69.6 (C(CO2Bn)2), 127.7 (CH=CHCH3), 128.6 (4 × Ph), 
128.8 (4 × Ph), 128.8 (2 × Ph), 134.7 (2 × i-Ph), 134.8 (CH=CHCOCH3), 
142.1 (CH=CHCOCH3), 145.6 (CH=CHCH3), 166.8 (2 × CO2Bn), 188.5 
(COCH=CH), 198.4 (COCH3); m/z (NSI+) 457 ([M+Na]+, 100%); HRMS 
(NSI+) C26H26NaO6+ ([M+Na]+) requires 457.1622, found 457.1610. 
Dimethyl (4aS,7S,7aR)-3,7-dimethyl-1-oxo-4a,5,7,7a-
tetrahydrocyclopenta[c]pyran-6,6(1H)-dicarboxylate 2f and 
dimethyl 2-((E)-but-2-enoyl)-2-((E)-4-oxopent-2-en-1-yl)malonate 
3f: Following General Procedure D, dimethyl (E)-2-(4-oxopent-2-en-1-
yl)malonate (107 mg, 0.5 mmol), LiHMDS (1 M in THF, 0.55 mL, 0.55 
mmol), HyperBTM 4 (30.8 mg, 0.10 mmol), iPr2NEt (0.12 mL, 0.7 mmol) 
and crotonoyl chloride (67 μL, 0.7 mmol) were reacted in THF (10 mL) to 
give a 73:27 mixture of 2f and 3f. The mixture was purified by 
chromatography on silica gel (20%→30% EtOAc/hexane) to afford 2f as a 
pale yellow oil (79 mg, 56%) and 3f as a pale yellow oil (28 mg, 20%). 2f: 
[𝛼]𝐷
20 (c0.98 in CH2Cl2); chiral HPLC analysis, ChiralPak AS-H (2.5% 
i-PrOH:hexane, flow rate 1 mL min-1, 211 nm, 30 °C), tR (4aS,7S,7aR): 9.3 
min, tR (4aR,7R,7aS): 15.8 min, 93.5:6.5 er; max (film)/cm-1 2955 (C-H), 
1726 (C=O); 1H NMR (300 MHz, CDCl3) δH: 1.14 (3H, d, J 6.9, C(7)CH3), 1.81 
(3H, dd, J 2.3, 1.1, C(3)CH3), 2.00 (1H, dd, J 14.0, 4.3, C(5)CHA), 2.71 (1H, 
ddd, J 11.2, 8.7, 0.8, C(7)H), 2.77 (1H, dd, J 14.0, 8.2, C(5)HB), 2.90 – 3.08 
(1H, m, C(7a)H), 3.06 – 3.17 (1H, m, C(4a)H), 3.71 (6H, d, J 3.0, 2 × CO2CH3), 
4.65 (1H, dp, J 2.3, 1.2, C(4)H); 13C{1H} NMR (75 MHz, CDCl3) δC: 15.2 
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(C(7)CH3), 18.8 (C(3)CH3), 34.8 (C(4a)H), 41.1 (C(5)H2), 44.1 (C(7)H), 48.2 
(C(7a)H), 52.6 (CO2CH3), 52.8 (CO2CH3), 62.2 (C(6)), 103.2 (C(4)H), 147.0 
(C(3)), 169.6 (C(1)), 171.2 (CO2CH3), 171.7 (CO2CH3); m/z (NSI+) 283 
([M+H]+, 100%); HRMS (NSI+) C14H19O6+ ([M+H]+) requires 283.1176, 
found 283.1177. 3f: max (film)/cm-1 2957 (C-H), 1732 (C=O), 1676 (C=O); 
1H NMR (300 MHz, CDCl3) δH: 1.92 (3H, dd, J 7.0, 1.7, CH=CHCH3), 2.21 (3H, 
s, COCH3), 3.00 (2H, dd, J 7.4, 1.4, CH2), 3.78 (6H, s, 2 × CO2CH3), 6.05 (1H, 
dt, J 16.0, 1.4, CH=CHCOCH3), 6.39 (1H, dq, J 15.1, 1.6, CH=CHCH3), 6.77 
(1H, dt, J 16.0, 7.3, CH=CHCOCH3), 7.05 (1H, dq, J 15.2, 7.0, CH=CHCH3); 
13C{1H} NMR (75 MHz, CDCl3) δC: 18.6 (CH=CHCH3), 26.7 (COCH3), 35.2 
(CH2), 53.4 (2 × CO2CH3), 69.7 (C(CO2CH3)2), 127.4 (CH=CHCH3), 134.7 
(CH=CHCOCH3), 142.2(CH=CHCOCH3), 145.9 (CH=CHCH3), 167.5 (2 × 
CO2CH3), 188.7 (COCH=CH), 198.5 (COCH3); m/z (NSI+) 283 ([M+H]+, 
100%); HRMS (NSI+) C14H19O6+ ([M+H]+) requires 283.1176, found 
283.1177. 
Dimethyl 1-oxo-3,7-diphenyl)-4a,5,7,7a-
tetrahydrocyclopenta[c]pyran-6,6(1H)-dicarboxylate 2g: Following 
General Procedure D, dimethyl (E)-2-(4-oxo-4-phenylbut-2-en-1-
yl)malonate (70 mg, 0.25 mmol), LiHMDS (1 M in THF, 0.28 mL, 0.28 
mmol), HyperBTM 4 (16 mg, 0.05 mmol), iPr2NEt (62 µL, 0.35 mmol) and 
cinnamoyl chloride (59 mg , 0.35 mmol) were reacted in THF (5.35 mL) to 
give 2g in 84:16 dr. The mixture was purified by chromatography on silica 
gel (EtOAc/Hexane 1:5) to afford 2g as a yellow oil in 93:7 dr (64.7 mg, 
64%). 2g: [𝛼]𝐷
20−17.0 (c 1.1 in CHCl3); chiral HPLC analysis, ChiralPak IA 
(2% i-PrOH:hexane, flow rate 1 mL min-1, 211 nm, 30 °C), tR (4aS,7S,7aR): 
23.5 min, tR (4aR,7R,7aS): 32.9 min, 82.0:18.0 er; max (film)/cm-1 2951 (C-
H), 2849 (C-H), 1759 (C=O), 1748 (C=O), 1724 (C=O); 1H NMR (500 MHz, 
CDCl3) δH: 2.30 (1H, dd, J 14.0, 4.4, C(5)HA), 3.18-3.12 (4H, m, CO2CH3, 
C(5)HB), 3.60-3.55 (1H, m, C(7a)H), 3.65-3.60 (1H, m, C(4a)H), 3.74 (3H, s, 
CO2CH3), 4.73 (1H, d, J 8.9, C(7)H), 5.60 (1H, d, J 2.5, C(4)H), 7.30-7.25 (1H, 
m, Ph), 7.35-7.30 (4H, m, 4 × Ph), 7.43-7.37 (3H, m, 3 × Ph), 7.66-7.60 (2H, 
m, 2 × Ph); 13C{1H} NMR (125 MHz, CDCl3) δC: 36.7 (C(4a)H), 41.2 (C(5)H2), 
47.6 (C(7a)H), 52.3 (CO2CH3), 53.1 (CO2CH3), 53.6 (C(7)H), 65.0 (C(6)), 
102.2 (C(4)H), 124.8 (2 × Ph), 127.8 (p-Ph), 128.3 (2 × Ph), 128.6 (2 × Ph), 
128.7 (2 × Ph), 129.2 (p-Ph), 132.1 (i-Ph), 137.3 (i-Ph), 149.2 (C(3)), 168.4 
(C(1)), 170.2 (CO2CH3), 171.6 (CO2CH3). Selected data for minor 
diastereomer: 1H NMR (500 MHz, CDCl3) δH: 4.54 (1H, d, J 11.8, C(7)H), 
6.12 (1H, d, J 2.1, C(4)H).  
Dimethyl 7-(4ˈ-methoxyphenyl)-1-oxo-3-phenyl)-4a,5,7,7a 
tetrahydrocyclopenta[c]pyran- 6,6(1H)-dicarboxylate 2h: Following 
General Procedure D, dimethyl (E)-2-(4-oxo-4-phenylbut-2-en-1-
yl)malonate (70 mg, 0.25 mmol), LiHMDS (1 M in THF, 0.28 mL, 0.28 
mmol), HyperBTM 4 (16 mg, 0.05 mmol), iPr2NEt (62 µL, 0.35 mmol) and 
4-methoxycinnamoyl chloride (70 mg , 0.35 mmol) were reacted in THF 
(5.4 mL) to give 2h in 92:8 crude dr. The mixture was purified by 
chromatography on silica gel (Toluene/CH2Cl2 1:5→CH2Cl2) to afford 2h 
as a yellow oil in 97:3 dr (40 mg, 37%). 2h: [𝛼]𝐷
20−21.7 (c 1.0 in CHCl3); 
chiral HPLC analysis, ChiralPak AS-H (5% i-PrOH:hexane, flow rate 1 mL 
min-1, 211 nm, 30 °C), tR (4aS,7S,7aR): 32.2 min, tR (4aR,7R,7aS): 48.2 min, 
72.0:28.0 er; max (film)/cm-1 2951 (C-H), 2839 (C-H), 1724 (C=O), 1748 
(C=O), 1610 (C=C), 1250 (C-O); 1H NMR (500 MHz, CDCl3) δH: 2.30 (1H, dd, 
J 14.0, 3.9, C(5)HA), 3.16-3.13 (1H, m, C(5)HB), 3.23 (3H, s, CO2CH3), 3.57-
3.52 (1H, m, C(7a)H), 3.62-3.56 (1H, m, C(4a)H), 3.73 (3H, s, CO2CH3), 3.80 
(3H, s, OCH3), 4.63 (1H, d, J 9.6, C(7)H), 5.57 (1H, d, J 3.2, C(4)H), 6.88-6.83 
(2H, m, 2 × Ar), 7.30-7.25 (2H, m, 2 × Ar), 7.43-7.36 (3H, m, 3 × Ph), 7.64-
7.60 (2H, m, 2 × Ph); 13C{1H} NMR (125 MHz, CDCl3) δC: 36.4 (C(4a)H), 41.1 
(C(5)H2), 47.6 (C(7a)H), 52.5 (CO2CH3), 53.0, 53.1 (C(7)H, CO2CH3), 55.2 
(OCH3), 64.8 (C(6)), 102.4 (C(4)H), 113.6 (2 × Ar), 124.8 (2 × Ar), 128.5 (2 
× Ar), 128.9 (Ar), 129.2 (Ar), 129.9 (2 × Ar), 132.2 (C(1ˈ)H), 149.0 (C(3)), 
159.0 (C(4ˈ)OMe), 168.4 (C(1)), 170.4 (CO2CH3), 171.7 (CO2CH3); m/z 
(ESI+) 459 ([M+Na]+, 100%); HRMS C25H24NaO7+ [M+Na]+ found 
459.1401, requires 459.14. Selected data for minor diastereomer: 1H NMR 
(500 MHz, CDCl3) δH: 4.48 (1H, d, J 11.7, C(7)H). 
Dimethyl (4aS,7S,7aR)-7-methyl-1-oxo-3-phenyl-4a,5,7,7a-
tetrahydrocyclopenta[c]pyran-6,6(1H)-dicarboxylate 2i and 
dimethyl 2-((E)-but-2-enoyl)-2-((E)-4-oxo-4-phenylbut-2-en-1-yl) 
malonate 3i: Following General Procedure D, dimethyl (E)-2-(4-oxo-4-
phenylbut-2-en-1-yl)malonate (40.6 mg, 0.15 mmol), LiHMDS (1 M in THF, 
0.15 mL, 0.15 mmol), HyperBTM 4 (9.1 mg, 0.03 mmol), EtN(iPr)2 (36 µL, 
0.21 mmol) and crotonyl chloride (20 µL , 0.21 mmol) were reacted in THF 
(3.2 mL) to give a 73:27 mixture of 2i and 3i, and 2i in 85:15 crude dr. The 
mixture was purified by chromatography on silica gel (EtOAc/Hexane 1:4) 
to afford 2i as a yellow oil in >95:5 dr (15.9 mg, 32%) and 3i as a yellow 
oil (10.2 mg, 20%). 2i: [𝛼]𝐷
20 +11.4 (c 0.6 in CHCl3); chiral HPLC analysis, 
ChiralPak AD-H (5% i-PrOH:hexane, flow rate 1 mL min-1, 211 nm, 30 °C), 
tR (4aS,7S,7aR): 21.9 min, tR (4aR,7R,7aS): 40.5 min, 93.5:6.5 er; max 
(film)/cm-1 2953 (C-H), 1728 (C=O); 1H NMR (500 MHz, CDCl3) δH: 1.25 
(3H, d, J 6.9, C(7)CH3), 2.22 (1H, dd, J 14.1, 4.4, C(5)HA), 2.96-2.89 (2H, m, 
C(5)HB, C(7a)H), 3.12 (1H, dq, J 11, 6.9, C(7)H), 3.44-3.37 (1H, m, C(4a)H), 
3.74 (3H, s, CO2CH3), 3.78 (3H, s, CO2CH3), 5.50 (1H, d, J 2.1, C(4)H), 7.41-
7.35 (3H, m, 3 × Ph), 7.62-7.58 (2H, m, 2 × Ph); 13C{1H} NMR (125 MHz, 
CDCl3) δC: 15.3 (CH3), 35.2 (C(4a)H), 41.1 (C(5)H2), 44.2 (C(7)H), 48.4 
(C(7a)H), 52.6 (CO2CH3), 52.8 (CO2CH3), 62.2 (C(6)), 103.1 (C(4)), 124.7 (2 
× Ph), 128.5 (2 × Ph), 129.1 (p-Ph), 132.2 (i-Ph), 147.8 (C(3)), 169.0 (C(1)), 
171.1 (CO2CH3), 171.5 (CO2CH3); m/z (ESI+) 367 ([M+Na]+, 100%); HRMS 
C19H20NaO6 [M+Na]+ found 367.1152, requires 367.1152. 3i: max 
(film)/cm-1 2953 (C-H), 2922 (C-H), 1732 (C=O), 1624 (C=C). 1H NMR (400 
MHz, CDCl3) δH: 1.94 (3H, dd, J 7.0, 1.7, CH3), 3.14 (2H, d, J 6.5, CH2), 3.82 
(6H, s, 2 × CO2CH3), 6.45 (1H, dq, J 15.2, 1.7, CH=CHCH3), 7.02-6.87 (2H, m, 
CH=CHCOPh), 7.08 (1H, dq, J 15.2, 7.0, CH=CHCH3), 7.53-7.45 (2H, m, 2 × 
Ph), 7.62-7.54 (1H, m, Ph), 7.94-7.87 (2H, m, 2 × Ph). 13C{1H} NMR (100 
MHz, CDCl3) δC: 18.5 (CH3), 35.4 (CH2), 53.3 (2 × CO2CH3), 127.3 
(CH=CHCH3), 128.6 (2 × Ph), 128.7 (2 × Ph), 130.0 (CH=CHCOPh), 132.8 
(p-Ph), 142.9 (CH=CHCOPh), 145.6 (i-Ph), 167.5 (2 × CO2CH3), 188.7 
(C=O), 190.6 (C=O); m/z (ESI+) 367 ([M+Na]+, 100%); HRMS C19H20NaO6 
[M+Na]+ found 367.1146, requires 367.1152. 
Dimethyl 1-oxo-3-phenyl-7-(4ˈ-(trifluoromethyl)phenyl)-4a,5,7,7a-
tetrahydrocyclopenta[c]pyran-6,6(1H)-dicarboxylate 2j: Following 
General Procedure D, dimethyl (E)-2-(4-oxo-4-phenylbut-2-en-1-
yl)malonate (60 mg, 0.22 mmol), LiHMDS (1 M in THF, 0.24 mL, 0.24 
mmol), HyperBTM 4 (14 mg, 0.04 mmol), iPr2NEt (53 µL, 0.30 mmol) and 
3-(4-trifluoromethyl-phenyl)acryloyl chloride (72 mg , 0.30 mmol) were 
reacted in THF (4.7 mL) to give 2j in 81:19 crude dr. The mixture was 
purified by chromatography on silica gel (Toluene/CH2Cl2 1:5) to afford 
2j as a yellow oil in 87:13 dr (20 mg, 0.04 mmol, 20%). 2j: [𝛼]𝐷
20 −16.8 (c 
1.0 in CHCl3); chiral HPLC analysis, ChiralPak AS-H (5% i-PrOH:hexane, 
flow rate 1 mL min-1, 211 nm, 30 °C), tR (4aS,7S,7aR): 12.6 min, tR 
(4aR,7R,7aS): 43.1 min, 82.5;17.5 er; max (film)/cm-1 2954 (C-H), 1726 
(C=O), 1111 (C-F); 1H NMR (500 MHz, CDCl3) δH: 2.31 (1H, dd, J 14, 4.6, 
C(5)HA), 3.16-3.13 (1H, m, C(5)HB), 3.18 (3H, s, CO2CH3), 3.62-3.56 (1H, m, 
C(7a)H), 3.69-3.63 (1H, m, C(4a)H), 3.76 (3H, s, CO2CH3), 4.74 (1H, d, J 9.7, 
C(7)H), 5.61 (1H, d, J 3.2, C(4)H), 7.44-7.38 (3H, m, 3 × Ar), 7.52-7.46 (2H, 
m, 2 × Ar), 7.64-7.55 (4H, m, 4 × Ar); 13C{1H} NMR (125 MHz, CDCl3) δC: 
36.5 (C(4a)H), 41.3 (C(5)H2), 47.2 (C(7a)H), 52.4 (C(7)H), 53.2 (2 × 
CO2CH3), 64.9 (C(6)), 102.1 (C(4)H), 124.1 (q, 1JCF 272.9, CF3), 124.8 (2 × 
Ar), 125.2 (q, 3JCF 3.9, C(3ˈ)H, C(5ˈ)H), 128.6 (2 × Ar), 129.4 (2 × Ar), 129.9 
(p-Ph), 130.0 (q, 2JCF 32.6, C(4ˈ)CF3), 131.9 (Ar), 141.2 (Ar), 149.2 (C(3)), 
168.0 (C(1)), 170.0 (CO2CH3), 171.3 (CO2CH3); δF (376 MHz, CDCl3) −62.7 
(CF3); m/z (ESI+) 497 ([M+Na]+, 100%); HRMS C25H21F3NaO6 [M+Na]+ 
found 497.1182, requires 497.1182. Selected data for minor 
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diastereomer: 1H NMR (500 MHz, CDCl3) δH: 2.08 (1H, dd, J 14.1, 5.8, 
C(5)H2), 4.66 (1H, d, J 10.7, C(7)H), 7.96-7.92 (2H, m, 2 × PhH).  
Trimethyl 2-methyl-4-(2-oxo-2-phenylethyl)cyclopentane-1,1,3-
tricarboxylate 7i: Following General Procedure E, dimethyl (E)-2-(4-oxo-
4-phenylbut-2-en-1-yl)malonate (70 mg, 0.25 mmol), LiHMDS (1 M in 
THF, 0.28 mL, 0.28 mmol), HyperBTM 4 (16 mg, 0.05 mmol), iPr2NEt (62 
µL, 0.35 mmol) and crotonyl chloride (34 µL , 0.35 mmol) were reacted in 
THF (5.5 mL). Subsequent ring-opening with MeOH (2.3 mL) and DMAP 
(6.1 mg, 0.05 mmol) gave 7i in 91:9 crude dr. The mixture was purified by 
chromatography on silica gel (EtOAc/Hexane 1:4) to afford 7i as a yellow 
oil in 99:1 dr (49.9 mg, 0.16 mmol, 64%). 7i:
 
 [𝛼]𝐷
20 +11.8 (c 1.0 in CHCl3); 
ChiralPak IC (10% i-PrOH:hexane, flow rate 1 mL min-1, 254 nm, 30 °C), tR 
(4aS,7S,7aR): 28.7 min, tR (4aR,7R,7aS): 36.2 min, 93.0:7.0 er; max 
(film)/cm-1 2953 (C-H), 2849 (C-H), 1724 (C=O), 1684 (C=O); 1H NMR 
(400 MHz, CDCl3) δH: 1.10 (3H, d, J 6.8, CH3), 1.91 (1H, dd, J 13.9, 7.4, 
C(5)HA), 2.79 (1H, dd, J 13.9, 7.7, C(5)HB), 3.01-2.86 (2H, m, C(3)H, 
CHAHBCOPh), 3.19-3.05 (2H, m, C(2)H, CHAHBCOPh), 3.34-3.22 (1H, m, 
C(4)H), 3.60 (3H, s, CO2CH3), 3.73 (3H, s, CO2CH3), 3.75 (3H, s, CO2CH3), 
7.50-7.44 (2H, m, 2 × Ph), 7.60-7.53 (1H, m, Ph), 7.94-7.88 (2H, m, 2 × Ph); 
13C{1H} NMR (100 MHz, CDCl3) δC: 15.1 (CH3), 34.7 (C(4)H), 40.8 (C(5)H2), 
40.9 (CH2COPh), 43.0 (C(2)H), 51.7 (CO2CH3), 52.3 (CO2CH3), 52.6 
(CO2CH3), 53.0 (C(3)H), 62.4 (C(1)), 127.9 (2 × Ph), 128.6 (2 × Ph), 133.1 
(p-Ph), 136.8 (i-Ph), 171.4 (CO2CH3), 172.0 (CO2CH3), 174.1 (CO2CH3), 
198.5 (COPh); m/z (ESI+) 399 ([M+Na]+, 100%); HRMS C20H24NaO7 
[M+Na]+ found 399.1412, requires 399.1414. Selected data for minor 
diastereomer: 1H NMR (400 MHz, CDCl3) δH: 1.07 (3H, d, J 6.8, CH3), 3.71 
(3H, s, CO2CH3), 8.00-7.95 (2H, m, 2 × PhH). 
Trimethyl (2S,3R,4S)-4-(2-oxo-2-phenylethyl)-2-(4ˈ-
(trifluoromethyl)phenyl)cyclopentane-1,1,3-tricarboxylate 7j: 
Following General Procedure E, dimethyl (E)-2-(4-oxo-4-phenylbut-2-en-
1-yl)malonate (60 mg, 0.22 mmol), LiHMDS (1 M in THF, 0.24 mL, 0.24 
mmol), HyperBTM 4 (14 mg, 0.04 mmol), iPr2NEt (53 µL, 0.30 mmol) and 
3-(4-trifluoromethyl-phenyl)acryloyl chloride (72 mg, 0.30 mmol) were 
reacted in THF (4.7 mL). Subsequent ring-opening with MeOH (2 mL) and 
DMAP (5.4 mg, 0.04 mmol) gave 7j in 84:16 crude dr. The mixture was 
purified by chromatography on silica gel (EtOAc/Hexane 1:4) to afford 7j 
as a yellow oil in 83:17 dr (70 mg, 64%). 7j: [𝛼]𝐷
20 −6.7 (c 1.1 in CHCl3); 
ChiralPak AD-H (5% i-PrOH:hexane, flow rate 1 mL min-1, 211 nm, 30 °C), 
tR (4aS,7S,7aR): 25.8 min, tR (4aR,7R,7aS): 33.3 min, 82.5:17.5 er; max 
(film)/cm-1 2953 (C-H), 2849 (C-H), 1726 (C=O), 1686 (C=O), 1114 (C-F); 
1H NMR (400 MHz, CDCl3) δH: 2.07 (1H, dd, J 14.1, 5.8, C(5)HA), 3.10-2.97 
(2H, m, C(5)HB, CHAHBCOPh), 3.22-3.14 (4H, m, CO2CH3, CHAHBCOPh), 
3.58-3.48 (4H, m, CO2CH3, C(4)H), 3.65-3.78 (4H, m, CO2CH3, C(3)H), 4.67 
(1H, d, J 4.67, C(2)H), 7.53-7.44 (4H, m, 4 × Ar), 7.64-7.53 (3H, m, 3 × Ar), 
7.98-7.92 (2H, m, 2 × Ar); 13C{1H} NMR (100 MHz, CDCl3) δC: 36.1 (C(4)H), 
40.1 (CH2COPh), 40.7 (C(5)H2), 51.5 (C(3)H), 51.8 (C(2)H), 51.9 (CO2CH3), 
52.1 (CO2CH3), 52.9 (CO2CH3), 64.5 (C(1)), 124.1 (q, 1JCF 272.0, CF3), 125.0 
(q, 3JCF 3.6, C(3ˈ)H, C(5ˈ)H), 128.0 (2 × Ar), 128.7 (2 × Ar), 129.0 (2 × Ar), 
129.6 (q, 2JCF 32.4, C(4ˈ)CF3), 133.3 (Ar), 136.8 (Ar), 142.3 (Ar), 170.6 
(CO2CH3), 172.2 (CO2CH3), 172.9 (CO2CH3), 198.1 (COPh); 19F{1H} NMR 
(376 MHz, CDCl3) δF: −62.6 (CF3); m/z (ESI+) 529 ([M+Na]+, 100%); HRMS 
C26H25F3NaO7 [M+Na]+ found 529.1443, requires 529.1445. Selected data 
for minor diastereomer: 1H NMR (400 MHz, CDCl3) δH: 3.77 (3H, s, 
CO2CH3), 4.52 (1H, d, J 12.2, C(2)H), 8.03-7.98 (2H, m, 2 × PhH). 
Trimethyl 4-(2-oxo-2-phenylethyl)-2-(thiophen-2ˈ-yl)cyclopentane-
1,1,3-tricarboxylate 7k: Following General Procedure E, dimethyl (E)-2-
(4-oxo-4-phenylbut-2-en-1-yl)malonate (91 mg, 0.33 mmol), LiHMDS (1 
M in THF, 0.37 mL, 0.37 mmol), HyperBTM 4 (21 mg, 0.07 mmol), iPr2NEt 
(81 µL, 0.46 mmol) and 3-(2-thienyl)acrylic chloride (80 mg , 0.46 mmol) 
were reacted in THF (7 mL). Subsequent ring-opening with MeOH (3 mL) 
and DMAP (8 mg, 0.07 mmol) gave 7k in 91:9 crude dr. The mixture was 
purified by chromatography on silica gel (EtOAc/Hexane 1:4) to afford 7k 
as a yellow oil in 92:8 dr (92.3 mg, 0.21 mmol, 63%). 7k: [𝛼]𝐷
20 -1.1 (c 1.0 
in CHCl3); chiral HPLC analysis, ChiralPak IB (2.5% i-PrOH:hexane, flow 
rate 1.5 mL min-1, 211 nm, 30 °C), tR (4aS,7S,7aR): 11.6 min, tR 
(4aR,7R,7aS): 15.4 min, 73.0;24.0 er; max (film)/cm-1 2951 (C-H), 2846 (C-
H), 1724 (C=O), 1684 (C=O); 1H NMR (500 MHz, CDCl3) δH: 2.00 (1H, dd, J 
14.2, 5.8, C(5)HA), 2.97 (1H, dd, J 17.5, 7.9, CHAHBCOPh), 3.06 (1H, dd, J 
14.2, 7.6, C(5)HB), 3.18 (1H, dd, J 17.5, 6.6, CHAHBCOPh), 3.36 (3H, s, 
CO2CH3), 3.52-3.46 (1H, m, C(4)H), 3.55 (3H, s, CO2CH3), 3.69 (1H, dd, J 
11.4, 8.5, C(3)H), 3.75 (3H, s, CO2CH3), 4.78 (1H, d, J 11.4, C(2)H), 6.92 (1H, 
dd, J 5.1, 3.5, C(3ˈ)H), 7.00-6.96 (1H, m, C(5ˈ)H), 7.17 (1H, dd, J 5.1, 1.1, 
C(4ˈ)H), 7.52-7.46 (2H, m, 2 × Ph), 7.62-7.56 (1H, m, Ph), 7.96-7.91 (2H, m, 
2 × Ph); 13C{1H} NMR (125 MHz, CDCl3) δC: 35.2 (C(4)H), 40.5 (CH2COPh), 
40.6 (C(5)H2), 47.7 (C(2)H), 52.0 (CO2CH3), 52.5 (CO2CH3), 52.8 (CO2CH3), 
52.9 (C(3)), 64.5 (C(1)), 124.6 (C(5ˈ)), 125.8 (C(4ˈ)), 126.5 (C(3ˈ)H), 128.0 
(2 × Ph), 128.7 (2 × Ph), 133.3 (p-Ph), 136.7 (i-Ph), 140.6 (C(2ˈ)), 170.7 
(CO2CH3), 172.0 (CO2CH3), 172.8 (CO2CH3), 198.1 (COPh); m/z (ESI+) 467 
([M+Na]+, 100%); HRMS C23H24NaO7S [M+Na]+ found 467.1125, requires 
467.1135. Selected data for minor diastereomer: 1H NMR (500 MHz, 
CDCl3) δH: 3.32 (3H, s, CO2CH3), 3.62 (3H, s, CO2CH3), 4.68 (1H, d, J 12, 
C(2)H), 8.02-7.98 (2H, m, 2 × Ph). 13C{1H} NMR (126 MHz, CDCl3) δC: 49.1 
(C(2)), 124.7 (C(5ˈ)), 140.1 (C(2ˈ)), 198.4 (COPh). 
Trimethyl 4-(2ˈ-(4ˈˈ-methoxyphenyl)-2-oxoethyl)-2-
methylcyclopentane-1,1,3-tricarboxylate 7l: Following General 
Procedure E, dimethyl (E)-2-(4-(4-methoxyphenyl)-4-oxobut-2-en-1-
yl)malonate (100 mg, 0.31 mmol), LiHMDS (1 M in THF, 0.34 mL, 0.34 
mmol), HyperBTM 4 (19 mg, 0.06 mmol), iPr2NEt (76 µL, 0.44 mmol) and 
crotonyl chloride (42 µL , 0.44 mmol) were reacted in THF (6.2 mL). 
Subsequent ring-opening with MeOH (3 mL) and DMAP (8 mg, 0.06 mmol) 
gave 7l in >95:5 crude dr. Purification via column chromatography on 
silica gel (Petrol/EtOAc, 3:1) gave 7l as a pale yellow oil (40 mg, 28%); 
[𝛼]𝐷
20 +10.5 (c1.0 in CHCl3); chiral HPLC analysis, ChiralPak IA (5% i-
PrOH:hexane, flow rate 1 mL min-1, 211 nm, 30 °C), tR (4aS,7S,7aR): 36.1 
min, tR (4aR,7R,7aS): 51.6 min, 96.0;4.0 er max (ATR)/cm-1 2953 (C−H), 
1724, 1724, 1674, 1599 (C=O); 1H NMR (500 MHz, CDCl3) δH: 1.07 (3H, d, 
J 6.8, C(2)Me), 1.87 (1H, dd, J 14.0, 7.3, C(5)HA), 2.75 (1H, dd, J 14.0, 7.7, 
C(5)HB), 2.82 (1H, dd, J 17.1, 8.0, C(1ˈ)HA), 2.94 (1H, dd, J 10.8, 9.2, C(3)H), 
3.00-3.11 (2H, m, C(2)H, C(1ˈ)HB), 3.20-3.29 (1H, m, C(4)H), 3.57 (3H, s, 
C(3)CO2Me), 3.71 (3H, s, C(1)CO2Me), 3.72 (3H, s, C(1)CO2Me), 3.85 (3H, s, 
OMe), 6.91 (2H, d, J 8.9, C(3ˈˈ)H, C(5ˈˈ)H), 7.87 (2H, d, J 8.9, C(2ˈˈ)H, C(6ˈˈ)H); 
13C{1H} NMR (125 MHz, CDCl3) δC: 15.2 (C(2)Me), 35.0 (C(4)), 40.6 (C(1ˈ)), 
40.8 (C(5)), 43.0 (C(2)), 51.8 (C(3)CO2CMe), 52.4, 52.7 (C(1)(CO2Me)2), 
53.1 (C(3)), 55.6 (OMe), 62.6 (C(1)), 113.8 (C(3ˈˈ), C(5ˈˈ)), 130.0 (C(1ˈˈ)), 
130.4 (C(2ˈˈ), C(6ˈˈ)), 163.6 (C(4ˈˈ)), 171.6, 172.2 (C(1)(CO2Me)2), 174.2 
(C(3)CO2Me), 197.1 (C(2ˈ)); m/z (ESI+) 429 ([M+Na]+, 100%); HRMS 
C21H26O8 [M+Na]+ found 429.1519, requires 429.1520. 
Trimethyl 4-(2-(4-methoxyphenyl)-2-oxoethyl)-2-
phenylcyclopentane-1,1,3-tricarboxylate 7m: Following General 
Procedure E, dimethyl (E)-2-(4-(4-methoxyphenyl)-4-oxobut-2-en-1-
yl)malonate (100 mg, 0.31 mmol), LiHMDS (1 M in THF, 0.34 mL, 0.34 
mmol), HyperBTM 4 (19 mg, 0.06 mmol), iPr2NEt (76 µL, 0.44 mmol) and 
cinnamoyl chloride (72 mg , 0.44 mmol) were reacted in THF (6.2 mL). 
Subsequent ring-opening with MeOH (3 mL) and DMAP (8 mg, 0.06 mmol) 
gave 7m in 83:17 dr. Purification via column chromatography on silica gel 
(Petrol/EtOAc, 3:1) gave 7m as a pale yellow oil (58 mg, 40%, 91:9 dr); 
[𝛼]𝐷
20 +11.0 (c1.0 in CHCl3); chiral HPLC analysis, ChiralPak IB (5% i-
PrOH:hexane, flow rate 1 mL min-1, 211 nm, 30 °C), tR (4aS,7S,7aR): 17.0 
min, tR (4aR,7R,7aS): 20.0 min, 81.0;19.0 er; max (ATR)/cm-1 2951 (C−H), 
1724, 1724, 1674, 1599 (C=O); 1H NMR (500 MHz, CDCl3) δH: 2.03 (1H, dd, 
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J 14.1, 5.7, C(5)HA), 2.93 (1H, dd, J 17.2, 7.9, C(1ˈ)HA), 3.01 (1H, dd, J 14.1, 
7.2, C(5)HB), 3.07 (1H, dd, J 17.2, 6.7, C(1ˈ)HB), 3.12 (3H, s, C(1)CO2Me), 
3.43-3.50 (1H, m, C(4)H), 3.48 (3H, s, C(3)CO2Me), 3.65 (1H, dd, J 10.5, 8.0 
C(3)H), 3.69 (3H, s, C(1)CO2Me), 3.87 (3H, s, OMe), 4.62 (1H, d, J 10.5, 
C(2)H), 6.96 (2H, d, J 9.0, C(3ˈˈ)H, C(5ˈˈ)H), 7.16-7.33 (5H, m, Ph), 7.94 (2H, 
d, J 9.0, C(2ˈˈ)H, C(6ˈˈ)H); 13C{1H} NMR (125 MHz, CDCl3) δC: 36.4 (C(4)), 
39.6 (C(1ˈ)), 40.7 (C(5)), 51.7 (C(3)CO2CMe), 51.8 (C(3)), 51.9 (C(2)), 52.1, 
52.8 (C(1)(CO2Me)2), 55.5 (OMe), 64.6 (C(1)), 113.8 (C(3ˈˈ), C(5ˈˈ)), 127.3 
(p-Ph), 128.1 (m-Ph), 128.3 (o-Ph), 129.9 (C(1ˈˈ)), 130.3 (C(2ˈˈ), C(6ˈˈ)), 
138.1 (i-Ph), 163.6 (C(4ˈˈ)), 170.8, 172.5 (C(1)(CO2Me)2), 173.3 
(C(3)CO2Me), 196.8 (C(2ˈ)); m/z (ESI+) 491 ([M+Na]+, 100%); HRMS 
C26H28NaO8+ [M+Na]+ found 491.1661, requires 491.1676. Selected data 
for minor diastereoisomer: 1H NMR (500 MHz, CDCl3) δH: 2.49 (1H, dd, J 
14.2, 10.3, C(5)HA), 2.66 (1H, dd, J 14.2, 8.5, C(5)HB), 3.41-3.35 (2H, m, 
C(1ˈ)H2), 3.56 (3H, s, Me), 3.76 (3H, s, Me), 4.48 (1H, d, J 12.0, C(2)H), 6.86 
(2H, d, J 8.0, Ar), 7.04-7.12 (3H, m, Ph), 7.37 (2H, d, J 8.2, Ph), 7.99 (2H, d, J 
8.0, Ar); 13C{1H} NMR (125 MHz, CDCl3) δC: 40.3 (C(5)), 42.0 (C(1ˈ)), 53.5 
(C(2)), 107.7 (Ar), 122.0, 122.1 (Ph), 130.4 (Ar).  
trimethyl 4-(2-oxo-2ˈ-(4ˈˈ-tolyl)ethyl)-2-phenylcyclopentane-1,1,3-
tricarboxylate 7n: Following General Procedure E, dimethyl (E)-2-(4-
oxo-4-(p-tolyl)but-2-en-1-yl)malonate (90 mg, 0.31 mmol), LiHMDS (1 M 
in THF, 0.34 mL, 0.34 mmol), HyperBTM 4 (19 mg, 0.06 mmol), iPr2NEt 
(76 µL, 0.44 mmol) and cinnamoyl chloride (72 mg , 0.44 mmol) were 
reacted in THF (6.2 mL), MeOH (3 mL) and DMAP (8 mg, 0.06 mmol) gave 
7n in 88:12 dr. Purification via column chromatography on silica gel 
(Petrol/EtOAc, 5:1) gave 7n as a pale yellow oil (73 mg, 51%, 88:12 dr); 
[𝛼]𝐷
20 −4.3 (c 1.0 in CHCl3); chiral HPLC analysis, ChiralPak AD-H (5%  
i-PrOH:hexane, flow rate 1 mL min-1, 211 nm, 30 °C), tR (4aS,7S,7aR): 41.1 
min, tR (4aR,7R,7aS): 47.2 min, 84.5;15.5 er; max (ATR)/cm-1 2951 (C−H), 
1728, 1728, 1682, 1607 (C=O); 1H NMR (500 MHz, CDCl3) δH: 2.03 (1H, dd, 
J 14.0, 5.8, C(5)HA), 2.41 (3H, s, C(4ˈˈ)Me), 2.95 (1H, dd, J 17.4, 7.2, C(1ˈ)HA), 
3.01 (1H, dd, J 14.0, 7.2, C(5)HB), 3.07-3.15 (1H, m, C(1ˈ)HB), 3.12 (3H, s, 
C(1)CO2Me), 3.44-3.51 (1H, m, C(4)H), 3.48 (3H, s, C(3)CO2Me), 3.65 (1H, 
dd, J 10.4, 8.0 C(3)H), 3.69 (3H, s, C(1)CO2Me), 4.62 (1H, d, J 10.4, C(2)H), 
7.15-7.33 (7H, m, Ph, Ar), 7.83 (2H, d, J 8.2, C(2ˈˈ)H, C(6ˈˈ)H); 13C NMR (125 
MHz, CDCl3) δC: 21.7 (Me), 36.4 (C(4)), 39.9 (C(1ˈ)), 40.7 (C(5)), 51.8 
(C(3)CO2CMe), 51.8 (C(3)), 51.9 (C(2)), 52.1, 52.8 (C(1)(CO2Me)2), 64.6 
(C(1)), 127.3 (p-Ph), 128.1 (m-Ph), 128.1 (C(2ˈˈ), C(6ˈˈ)), 128,5 (o-Ph), 
129.3 (C(3ˈˈ), C(5ˈˈ)), 134.4 (C(1ˈˈ)), 138.1 (i-Ph), 144.0 (C(4ˈˈ)), 170.8, 172.5 
(C(1)(CO2Me)2), 173.3 (C(3)CO2Me), 197.9 (C(2ˈ)); m/z (ESI+) 475 
([M+Na]+, 100%); HRMS C26H28O7 [M+Na]+ found 475.1725, requires 
475.1727. Selected data for minor diastereoisomer: 1H NMR (500 MHz, 
CDCl3) δH: 2.49 (1H, dd, J 14.2, 10.3, C(5)HA), 2.67 (1H, dd, J 14.2, 8.5, 
C(5)HB), 3.19-3.28 (1H, m, C(1ˈ)HA), 3.42 (1H, dd, J 17.3, 4.3, C(1ˈ)HB), 3.53 
(3H, s, Me), 3.73 (3H, s, Me), 4.49 (1H, d, J 12.0, C(2)H), 7.90 (2H, d, J 8.0, 
Ar); 13C{1H} NMR (125 MHz, CDCl3) δC: 37.4 (C(4)), 40.3 (C(5)), 42.7 
(C(1ˈ)), 53.2 (C(2)), 53.5 (C(3)), 64.3 (C(1)), 128.2 (Ar), 134.2 (C(1ˈˈ)), 
137.5 (i-Ph), 171.7, 172.0 (C(1)CO2Me), 173.1 (C(3)CO2Me), 198.0 (C(2ˈ)). 
Trimethyl 4-(2ˈ-(4ˈˈ-fluorophenyl)-2-oxoethyl)-2-
phenylcyclopentane-1,1,3-tricarboxylate 7o: Following General 
Procedure E, (E)-2-(4-(4-fluorophenyl)-4-oxobut-2-en-1-yl)malonate (92 
mg, 0.31 mmol), LiHMDS (1 M in THF, 0.34 mL, 0.34 mmol), HyperBTM 4 
(19 mg, 0.06 mmol), EtN(iPr)2 (76 µL, 0.44 mmol) and cinnamoyl chloride 
(72 mg , 0.44 mmol) were reacted in THF (6.2 mL), MeOH (3 mL) and 
DMAP (8 mg, 0.06 mmol) gave 7o in 91:9 dr. Purification via column 
chromatography on silica gel (Petrol/EtOAc, 5:1) gave 7o as a pale yellow 
oil (43 mg, 30%, 91:9 dr); [𝛼]𝐷
20 −4.0 (c 1.0 in CHCl3); chiral HPLC analysis, 
ChiralPak IB (2% i-PrOH:hexane, flow rate 1 mL min-1, 211 nm, 30 °C), tR 
(4aS,7S,7aR): 16.0 min, tR (4aR,7R,7aS): 20.2 min, 76.0:24.0 er; max 
(ATR)/cm-1 2953 (C−H), 1724, 1724, 1684, 1597 (C=O); 1H NMR (400 
MHz, CDCl3) δH: 2.02 (1H, dd, J 14.3, 5.7, C(5)HA), 2.94 (1H, dd, J 17.5, 7.5, 
C(1ˈ)HA), 3.03 (1H, dd, J 14.0, 7.3, C(5)HB), 3.11-3.17 (1H, m, C(1ˈ)HB), 3.12 
(3H, s, C(1)CO2Me), 3.48 (3H, s, C(3)CO2Me), 3.43-3.50 (1H, m, C(4)H), 3.65 
(1H, dd, J 10.5, 7.9, C(3)H), 3.70 (3H, s, C(1)CO2Me), 4.61 (1H, d, J 10.5, 
C(2)H), 7.10-7.17 (2H, m, C(3ˈˈ)H, C(5ˈˈ)H), 7.23-7.33 (5H, m, Ph), 7.92-7.99 
(2H, m, C(2ˈˈ)H, C(6ˈˈ)H); 13C{1H} NMR (100 MHz, CDCl3) δC: 36.3 (C(4)H), 
40.0 (C(1ˈ)), 40.7 (C(5)), 51.7 (C(3)CO2Me), 51.8 (C(3)), 52.0 (C(2)), 52.1 
(C(1)CO2Me), 52.9 (C(1)CO2Me), 64.6 (C(1)), 115.8 (d, J 21.9, C(3ˈˈ), C(5ˈˈ)), 
127.4 (p-Ph), 128.1 (m-Ph), 128.5 (o-Ph), 130.6 (d, J 9.3, C(2ˈˈ), C(6ˈˈ)), 
138.0 (i-Ph), 165.8 (d, J 255.0 C(4ˈˈ)), 170.8, 172.5 (C(1)CO2Me), 173.3 
(C(3)CO2Me), 196.7 (C(2ˈ)); m/z (ESI+) 479 ([M+Na]+, 100%); HRMS 
C25H25FNaO7+ [M+Na]+ found 479.1464, requires 479.1477. 
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Kucsman, R. A. Poirier, I. G. Csizmadia, J. Mol. Struct.: THEOCHEM 
1985, 123, 189−201; (c) J. S. Murray, P. Lane, P. Politzer, Int. J. 
Quantum Chem. 2008, 108, 2770−2781; (d) M. Iwaoka, S. 
Takemoto, S. Tomoda, J. Am. Chem. Soc. 2002, 124, 10613−10620; 
(e). K. A. Brameld, B. Kuhn, D. C. Reuter, M. Stahl, J. Chem. Inf. Model., 
2008, 48, 1-24. 
(27) X. Han and R. A. Widenhoefer, J. Org. Chem., 2004, 69, 1738-1740. 
(28) F. Poulhès, R. Sylvain, P. Perfetti, M. P. Bertrand, G. Gil and S. 
Gastaldi, Synthesis, 2010, 8, 1334-1338. 
(29) Phosphoranes were prepared according to a procedure detailed 
within the following: D. G. Stark, L. C. Morrill, P.-P. Yeh, A. M. Z. 
Slawin, T. J. C. O’Riordan, and A. D. Smith, Angew. Chem. Int. Ed. 
2013, 52, 11642-11646. 
 
 
